Dermatographic urticaria

L12_URTICA_DERTMATOG

dermatographia: Familial dermographism is a condition also known as skin writing. When people who have dermatographia lightly scratch their skin, the scratches redden into a raised wheal similar to hives. Signs and symptoms of dermatographia include raised red lines, swelling, inflammation, hive-like welts and itching. Symptoms usually disappear within 30 minutes. The exact cause of this condition is unknown. Treatment mayinvovle use of antihistamines if symptoms do not go away on their own.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L50.3 Hospital discharge: ICD-9 — 7083 Cause of death: ICD-10 — L50.3 Cause of death: ICD-9 — 7083 2 out of 7 registries used, show all original rules.	3176
4. Check minimum number of events None	3176
5. Include endpoints None	3176
6. Filter based on genotype QC (FinnGen only)	2889

Control definitions (FinnGen only)

Control exclude: L12_URTICARIAERYTHEMA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L50
Name in latin: Urticaria derm[at]ographica

NAME	L12_URTICA_DERTMATOG
CONTROL_EXCLUDE	L12_URTICARIAERYTHEMA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L503
HD_ICD_9	7083
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L503
COD_ICD_9	7083
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Dermatographic urticaria based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	15685	11264	4351
Only index persons	15227	11048	4179
Unadjusted period prevalence (%)
Whole population	0.27	0.32	0.12
Only index persons	0.34	0.41	0.16
Median age at first event (years)
Whole population	41.50	41.98	40.28
Only index persons	41.59	42.07	40.32

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2889	2288	601
Unadjusted period prevalence (%)	0.70	0.81	0.28
Median age at first event (years)	46.57	45.00	52.53

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3012: Matched controls
30120

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L50.8

ICD-10 Finland

Other urticaria

72.0

307.7

322

L50.9

ICD-10 Finland

Urticaria, unspecified

25.9

307.7

576

273

R06AX27

ATC

desloratadine; oral

5.3

307.7

1887

7262

XQ800

NOMESCO Finland

Prick test

8.4

307.7

854

1361

R06AE09

ATC

levocetirizine; oral

5.1

307.7

1091

2993

L50.3

ICD-10 Finland

Dermatographic urticaria

60365.0

307.7

2974

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

8.4

307.7

1007

1700

R06AE07

ATC

cetirizine; oral

4.0

278.7

2101

10958

C01CA24

ATC

epinephrine; parenteral

5.9

273.1

553

1097

L50.0

ICD-10 Finland

Allergic urticaria

14.2

269.9

253

193

L50.1

ICD-10 Finland

Idiopathic urticaria

55.1

267.8

152

XQ802

NOMESCO Finland

Epicutan test

6.8

235.5

397

654

R03DC03

ATC

montelukast; oral

3.7

225.6

983

3501

E0000UV, ,

ATC

3.2

212.5

1833

9767

H02AB06

ATC

prednisolone; systemic

3.2

205.9

1869

10190

L30.9

ICD-10 Finland

Dermatitis, unspecified

3.3

199.1

1104

4518

T78.4

ICD-10 Finland

Allergy, unspecified

5.7

188.6

379

737

L29.9

ICD-10 Finland

Pruritus, unspecified

7.3

186.2

286

424

D07AC01

ATC

betamethasone; topical

2.8

168.6

1483

7683

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

4.4

160.8

459

1192

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

13.4

153.7

147

115

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

6.2

148.9

267

463

R06AX22

ATC

ebastine; oral

3.0

146.5

881

3680

L50.2

ICD-10 Finland

Urticaria due to cold and heat

69.9

137.7

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

4.8

124.3

301

682

D07AB02

ATC

hydrocortisone butyrate; topical

2.4

114.1

1189

6380

T78.3

ICD-10 Finland

Angioneurotic oedema

10.7

111.0

122

118

D07AB08

ATC

desonide; topical

3.1

109.2

519

1869

L50

ICD-10 Finland

Urticaria

7.0

107.9

170

257

E000001, ,

ATC

2.5

100.8

835

3998

D07AC13

ATC

mometasone; topical

2.3

99.7

1092

5915

R06AX13

ATC

loratadine; oral

2.5

92.0

711

3279

L20.0

ICD-10 Finland

Besnier prurigo

3.0

88.4

450

1673

R03AC02

ATC

salbutamol; inhalant

2.2

84.3

1961

13985

D07AA02

ATC

hydrocortisone; topical

2.5

83.2

615

2763

E000002, ,

ATC

2.7

78.5

495

2054

D07AD01

ATC

clobetasol; topical

2.4

78.1

658

3131

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

74.2

944

5310

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.0

74.2

1383

8943

L29

ICD-10 Finland

Pruritus

6.6

73.5

120

188

L29.8

ICD-10 Finland

Other pruritus

6.8

71.9

114

173

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

69.3

725

3760

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.7

69.0

423

1724

A02BA02

ATC

ranitidine; systemic

2.3

67.2

599

2902

N02AX02

ATC

tramadol; systemic, rectal

1.9

66.5

1319

8617

TQW80

NOMESCO Finland

Local dermatologic skincare

5.2

66.1

140

281

A02BC05

ATC

esomeprazole; systemic

1.9

65.5

1328

8726

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

7.4

63.2

127

R01AD09

ATC

mometasone; nasal

1.9

62.3

1645

11713

D02AX

ATC

Other emollients and protectives

4.2

61.3

168

416

M25.5

ICD-10 Finland

Pain in joint

1.9

58.2

1214

7966

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.1

57.3

677

3650

M54.5

ICD-10 Finland

Low back pain

1.8

55.6

1306

8857

344

Kela drug reimbursment

Omalizumab

286.7

55.4

N03AX12

ATC

[U] gabapentin; oral

2.2

55.1

554

2802

J45

ICD-10 Finland

Asthma

2.4

54.8

440

2024

XQ820

NOMESCO Finland

Exposure to medicinal substance

12.5

54.8

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

54.2

1317

9005

L28.1

ICD-10 Finland

Prurigo nodularis

10.0

52.6

R01AD08

ATC

fluticasone; nasal

1.9

52.3

1034

6617

R51.80

ICD-10 Finland

Headache

2.0

51.9

662

3655

A02BC03

ATC

lansoprazole; oral

1.9

51.8

859

5192

A02BC02

ATC

pantoprazole; systemic

1.9

51.6

2082

16465

H02AB07

ATC

prednisone; oral

2.3

51.1

441

2089

S98

ICPC

Urticaria

8.8

50.9

L30.3

ICD-10 Finland

Infective dermatitis

3.7

50.8

165

461

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

3.1

50.5

219

735

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

6.5

49.9

129

N06AX21

ATC

duloxetine; oral

2.2

49.8

485

2414

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.4

49.5

395

1807

D02AE01

ATC

carbamide; topical

2.8

49.4

258

961

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

2.2

49.4

496

2498

M54.4

ICD-10 Finland

Lumbago with sciatica

2.0

47.5

665

3782

R03DX05

ATC

omalizumab; parenteral

243.8

47.1

R03BA05

ATC

fluticasone; inhalant

2.0

46.7

651

3693

R06AX26

ATC

fexofenadine; oral

2.5

46.7

321

1371

M79.6

ICD-10 Finland

Pain in limb

1.7

46.4

1464

10640

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

46.1

1389

9960

R01AD12

ATC

fluticasone furoate; nasal

1.8

45.7

1187

8159

N03AX16

ATC

[U] pregabalin

1.9

45.7

718

4238

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.5

45.5

321

1387

G44.2

ICD-10 Finland

Tension-type headache

2.0

45.1

561

3055

H02AB04

ATC

methylprednisolone; systemic

2.1

44.6

475

2440

A92

ICPC

Allergy/allergic reaction NOS

3.3

44.6

178

568

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

5.0

44.4

196

J01FA10

ATC

azithromycin; systemic

1.7

43.9

1944

15406

SPAT1263

SPAT

Sampling

1.7

43.4

1316

9401

J01AA02

ATC

doxycycline; systemic

1.9

43.4

2335

19545

L50.5

ICD-10 Finland

Cholinergic urticaria

423.5

42.3

M79.1

ICD-10 Finland

Myalgia

1.9

42.2

595

3377

X59

ICD-10 Finland

Exposure to unspecified factor

1.9

42.1

626

3616

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

42.1

1036

6975

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.8

42.0

985

6540

UJF32

NOMESCO Finland

Coloscopy

1.9

41.7

722

4379

M03BX02

ATC

tizanidine; oral

1.7

41.2

1986

15965

XQ848

NOMESCO Finland

Dermatological photography

3.9

41.0

125

334

S02

ICPC

Pruritus

3.2

40.9

171

561

XQ801

NOMESCO Finland

Intracutantest

8.4

40.7

7083A

ICD-9 Finland

Urticaria, Dermatographic urticaria

+∞

40.7

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

40.4

731

4487

A02BC01

ATC

omeprazole; systemic

1.8

39.8

806

5114

J02AC01

ATC

fluconazole; systemic

1.7

39.8

1427

10576

E000007, ,

ATC

2.7

39.6

231

909

R06.0

ICD-10 Finland

Dyspnoea

1.8

39.0

800

5092

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.9

38.2

187

671

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

38.0

934

6248

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.8

37.6

695

4282

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.2

37.3

363

1794

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

37.3

639

3847

R01AD58

ATC

fluticasone, combinations; nasal

1.7

36.9

962

6529

R03AK08

ATC

formoterol and beclometasone; inhalant

2.8

36.7

189

697

R03BA02

ATC

budesonide; inhalant

1.8

36.7

611

3644

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

36.4

1310

9646

R03BA08

ATC

ciclesonide; inhalant

2.2

36.2

329

1582

M01AH05

ATC

etoricoxib; oral

1.6

36.0

1935

15707

S29

ICPC

Skin symptom/complaint other

1.8

35.9

657

4029

N05BB01

ATC

hydroxyzine; systemic

2.5

35.9

231

954

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

35.3

1843

14816

J01FA06

ATC

roxithromycin; oral

1.6

35.3

1206

8748

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

4.0

35.3

101

258

R42

ICD-10 Finland

Dizziness and giddiness

1.8

35.2

675

4193

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

35.0

812

5323

E000006, ,

ATC

2.5

35.0

240

1021

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

34.9

779

5054

J45.1

ICD-10 Finland

Nonallergic asthma

2.4

34.8

249

1080

L23.5

ICD-10 Finland

Allergic contact dermatitis due to other chemical products

6.3

34.7

ZXE00

NOMESCO Finland

One hour or less

1.6

34.6

1182

8560

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.9

34.4

163

574

J01FF01

ATC

clindamycin; systemic

1.7

34.4

808

5312

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

34.3

1235

9057

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

34.1

1227

8993

R60.9

ICD-10 Finland

Oedema, unspecified

2.7

34.0

187

714

N02BE01

ATC

paracetamol; systemic, rectal

2.1

33.9

2701

24252

R03BA01

ATC

beclometasone; inhalant

2.0

33.9

446

2457

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.1

33.9

144

477

S88

ICPC

Dermatitis contact/allergic

3.8

33.7

103

276

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

33.6

770

5024

UKC02

NOMESCO Finland

Cystoscopy

2.1

33.2

353

1802

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

33.1

761

4967

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.4

32.8

243

1070

J01DB01

ATC

cefalexin; oral

1.8

32.6

2523

22215

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.2

32.2

298

1440

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.9

32.2

459

2594

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

31.9

732

4768

C07AB07

ATC

bisoprolol; oral

1.6

31.6

1139

8309

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.1

31.5

310

1535

S01GX01

ATC

cromoglicic acid; ophthalmic

1.7

31.1

730

4777

H04.10

ICD-10 Finland

Dry eye syndrome

1.9

31.1

415

2293

H53.1

ICD-10 Finland

Subjective visual disturbances

2.3

30.6

254

1174

SPAT1312

SPAT

General health counselling

1.6

30.5

990

7029

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

5.1

30.3

128

B86

ICD-10 Finland

Scabies

3.1

30.3

130

433

J31.0

ICD-10 Finland

Chronic rhinitis

2.1

30.2

317

1607

R53

ICD-10 Finland

Malaise and fatigue

1.6

30.1

827

5633

XQ810

NOMESCO Finland

Physical test for urticaria

83.5

29.8

R02

ICPC

Shortness of breath/dyspnoea

1.9

29.7

412

2303

L23.8

ICD-10 Finland

Allergic contact dermatitis due to other agents

7.0

29.7

J01FA09

ATC

clarithromycin; systemic

1.6

29.6

984

7015

J01MA02

ATC

ciprofloxacin; systemic

1.6

29.6

1019

7327

L23.9

ICD-10 Finland

Allergic contact dermatitis, unspecified cause

5.4

29.5

109

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

29.2

420

2377

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.7

29.1

746

4986

XKD00

NOMESCO Finland

Uroflowmetry

2.2

28.9

265

1274

SPAT1301

SPAT

No procedures

1.6

28.9

872

6068

D09AB01

ATC

zinc bandage without supplements; topical

4.4

28.8

170

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.9

28.8

441

2544

L85.3

ICD-10 Finland

Xerosis cutis

5.7

28.8

N06AX16

ATC

venlafaxine; oral

1.8

28.6

524

3191

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.1

28.3

292

1470

R05

ICD-10 Finland

Cough

1.7

28.3

679

4457

SPAT1153

SPAT

Removal of sutures

1.6

28.3

804

5509

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

28.1

398

2238

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

28.1

2299

19973

R52.9

ICD-10 Finland

Pain, unspecified

2.0

27.8

343

1842

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

27.7

903

6388

N02BF01

ATC

gabapentin; oral

2.0

27.5

349

1891

K07.60

ICD-10 Finland

Snapping jaw

2.2

27.4

234

1093

L30.0

ICD-10 Finland

Nummular dermatitis

2.8

27.3

136

493

K30

ICD-10 Finland

Functional dyspepsia

1.9

27.2

400

2277

L30.8

ICD-10 Finland

Other specified dermatitis

3.0

27.1

121

412

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.0

27.1

331

1771

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.0

27.0

338

1824

M79.7

ICD-10 Finland

Fibromyalgia

2.6

26.8

159

630

J01MA12

ATC

levofloxacin; systemic

1.8

26.8

468

2807

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.8

26.5

458

2738

R13

ICD-10 Finland

Dysphagia

2.3

26.4

217

998

R51

ICD-10 Finland

Headache

2.2

26.3

236

1125

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

26.3

425

2490

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

26.3

435

2567

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.8

26.1

442

2626

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.1

26.0

277

1410

L03

ICPC

Low back symptom/complaint

1.6

25.6

954

6933

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.7

25.5

555

3539

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.3

25.3

198

891

L04AD01

ATC

ciclosporin; systemic

3.9

25.3

197

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

25.2

1266

9796

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

3.7

25.2

225

NH3EA

NOMESCO Finland

Feet X-ray examination with load

3.6

25.0

240

J46

ICD-10 Finland

Status asthmaticus

3.0

24.7

112

385

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

24.7

821

5806

N05BA04

ATC

oxazepam; oral

1.6

24.6

787

5516

P01AB01

ATC

metronidazole; oral, rectal

1.5

24.5

1247

9658

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.3

24.5

202

930

R60.0

ICD-10 Finland

Localized oedema

1.9

24.5

337

1875

M54.2

ICD-10 Finland

Cervicalgia

2.0

24.5

285

1498

R00.2

ICD-10 Finland

Palpitations

2.0

24.4

295

1571

A07AA02

ATC

nystatin; oral

2.4

24.4

172

740

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.6

24.3

145

577

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.9

24.2

308

1668

J45.8

ICD-10 Finland

Mixed asthma

3.0

24.1

109

374

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

2.1

24.1

253

1280

AA1AD

NOMESCO Finland

CT of head and brain

1.6

23.4

677

4626

Z01.9

ICD-10 Finland

Special examination, unspecified

2.2

23.2

198

924

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.1

23.2

229

1132

X49

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

5.2

23.1

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.0

23.1

263

1371

Z3231

NOMESCO Finland

Registered nurse

1.6

23.0

727

5070

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

22.9

607

4058

UDC00

NOMESCO Finland

Ear microscopy

2.1

22.9

223

1097

G50.1

ICD-10 Finland

Atypical facial pain

3.4

22.9

240

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.0

22.8

274

1454

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.9

22.8

304

1672

J01DA01

ATC

[U] cefalexin

1.5

22.7

1795

15073

R20.2

ICD-10 Finland

Paraesthesia of skin

2.0

22.7

253

1309

XQ899

NOMESCO Finland

Other assessment of skin

7.8

22.5

A03FA02

ATC

cisapride; oral, rectal

2.2

22.5

196

923

A02BC04

ATC

rabeprazole; oral

1.9

22.4

290

1579

J30.3

ICD-10 Finland

Other allergic rhinitis

2.5

22.2

149

626

L73.8

ICD-10 Finland

Other specified follicular disorders

4.5

22.2

122

R01AD01

ATC

beclometasone; nasal

1.7

22.2

473

2989

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.8

22.1

397

2392

R96

ICPC

Asthma

1.9

22.1

313

1756

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

22.0

581

3879

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.2

21.9

181

834

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.9

21.7

307

1721

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.7

21.7

115

431

R07.0

ICD-10 Finland

Pain in throat

1.9

21.6

280

1524

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.2

21.6

190

898

K08.80

ICD-10 Finland

Toothache NOS

1.8

21.5

336

1943

R52.2

ICD-10 Finland

Other chronic pain

2.5

21.4

140

582

SPAT1260

SPAT

Consultation of another employee

1.7

21.3

485

3116

L28.2

ICD-10 Finland

Other prurigo

7.9

21.3

L20.8

ICD-10 Finland

Other atopic dermatitis

4.0

21.0

149

N06AX11

ATC

mirtazapine; oral

1.5

21.0

994

7525

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.9

20.9

259

1390

M01AB05

ATC

diclofenac; systemic, rectal

1.5

20.8

1902

16282

G47.3

ICD-10 Finland

Sleep apnoea

1.6

20.8

599

4074

L12

ICPC

Hand/finger symptom/complaint

1.6

20.8

552

3683

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

3.3

20.8

235

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

4.3

20.4

122

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.7

20.3

406

2519

J20

ICD-10 Finland

Acute bronchitis

1.8

20.2

330

1931

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

20.0

1673

14039

L04AX03

ATC

methotrexate; systemic

1.8

19.8

293

1663

R03AC13

ATC

formoterol; inhalant

2.3

19.8

151

672

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.1

19.8

186

902

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.9

19.5

282

1589

H02AB09

ATC

hydrocortisone; systemic

3.0

19.5

297

S18

ICPC

Laceration/cut

1.4

19.4

1233

9829

R03AC03

ATC

terbutaline; inhalant

1.7

19.3

424

2694

P01BA02

ATC

hydroxychloroquine; oral

1.9

19.3

253

1383

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

19.1

483

3178

R50.9

ICD-10 Finland

Fever, unspecified

1.7

19.0

429

2745

ZXA10

NOMESCO Finland

Bilateral

1.6

19.0

458

2980

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

18.9

406

2564

WZC30

NOMESCO Finland

Teaching

1.6

18.8

442

2856

J01EA01

ATC

trimethoprim; systemic

1.5

18.7

769

5635

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.4

18.7

130

556

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

18.7

835

6223

M70.6

ICD-10 Finland

Trochanteric bursitis

1.7

18.6

393

2470

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

18.6

927

7054

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

18.6

316

1871

R06.4

ICD-10 Finland

Hyperventilation

3.5

18.5

182

R03BB04

ATC

tiotropium bromide; inhalant

1.9

18.5

226

1205

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.1

18.4

176

859

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

18.2

279

1600

M01AE02

ATC

naproxen; oral, rectal

1.4

18.2

1711

14545

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.0

18.2

197

1007

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.8

18.2

268

1519

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.6

18.2

108

429

J01DA09

ATC

[U] cefadroxil

1.5

18.2

758

5567

L17

ICPC

Foot/toe symptom/complaint

1.5

18.1

873

6592

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

18.1

988

7635

R03AC12

ATC

salmeterol; inhalant

2.5

18.1

118

490

M54.6

ICD-10 Finland

Pain in thoracic spine

1.9

18.1

257

1441

M01AH01

ATC

celecoxib; oral

1.6

18.0

447

2928

J05AB01

ATC

aciclovir; systemic

1.5

17.9

660

4722

D01

ICPC

Abdominal pain/cramps general

1.6

17.9

423

2734

SPAT1310

SPAT

Counselling related to known health issue

1.5

17.9

874

6612

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

17.9

1412

11636

L53.9

ICD-10 Finland

Erythematous condition, unspecified

4.3

17.8

105

L08

ICPC

Shoulder symptom/complaint

1.5

17.8

650

4643

M01AC06

ATC

meloxicam; systemic, rectal

1.4

17.7

959

7394

WX402

NOMESCO Finland

General anaesthesia

1.5

17.7

656

4698

N06AA09

ATC

amitriptyline; systemic

1.9

17.6

250

1400

G43.3

ICD-10 Finland

Complicated migraine

2.8

17.6

331

R21

ICPC

Throat symptom/complaint

1.5

17.6

770

5702

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

17.3

413

2676

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.0

17.3

247

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

17.2

930

7160

A01AB09

ATC

miconazole; local oral

1.9

17.2

231

1271

L01

ICPC

Neck symptom/complaint

1.5

17.1

541

3742

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

17.1

810

6084

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.8

17.1

291

1723

M54

ICD-10 Finland

Dorsalgia

1.6

16.6

414

2711

S01

ICPC

Pain/tenderness of skin

2.2

16.5

146

691

H03AA01

ATC

levothyroxine sodium; systemic

1.5

16.5

681

4974

M02AA07

ATC

piroxicam; topical

1.4

16.5

861

6577

D07CC01

ATC

betamethasone and antibiotics; topical

1.7

16.4

353

2226

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

16.4

1559

13181

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.7

16.4

327

2023

R05

ICPC

Cough

1.5

16.4

752

5610

C07AA05

ATC

propranolol; systemic

1.5

16.2

633

4571

H01

ICPC

Ear pain/earache

1.6

16.2

394

2562

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.7

16.2

316

1942

G43.9

ICD-10 Finland

Migraine, unspecified

1.8

16.2

252

1452

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.8

16.1

270

1590

J01FA01

ATC

erythromycin; systemic

1.6

16.1

444

2977

L23.3

ICD-10 Finland

Allergic contact dermatitis due to drugs in contact with skin

5.6

16.0

Z01.2

ICD-10 Finland

Dental examination

1.4

15.9

1467

12317

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

15.9

297

1805

R30.0

ICD-10 Finland

Dysuria

2.1

15.7

146

705

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

2.1

15.6

152

747

L71.9

ICD-10 Finland

Rosacea, unspecified

2.5

15.6

100

413

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.8

15.6

279

D07XC01

ATC

betamethasone; topical

1.7

15.5

300

1838

R01AD11

ATC

triamcinolone; nasal

1.8

15.5

262

1546

M13.9

ICD-10 Finland

Arthritis, unspecified

1.9

15.5

218

1218

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

2.6

15.5

331

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.1

15.4

146

710

L27.2

ICD-10 Finland

Dermatitis due to ingested food

4.1

15.4

100

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.0

15.3

173

898

N02BF02

ATC

pregabalin; oral

1.9

15.3

208

1149

L71.8

ICD-10 Finland

Other rosacea

2.9

15.2

238

S06.0

ICD-10 Finland

Concussion

1.7

15.0

304

1885

SFA20

NOMESCO Finland

Two-surface restoration

1.4

15.0

1779

15478

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.9

14.9

198

1085

F45.8

ICD-10 Finland

Other somatoform disorders

1.7

14.8

266

1597

SFA10

NOMESCO Finland

One-surface restoration

1.4

14.8

1676

14464

L43.9

ICD-10 Finland

Lichen planus, unspecified

2.9

14.7

232

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.8

14.7

242

1418

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

14.7

1070

8617

L28.0

ICD-10 Finland

Lichen simplex chronicus

4.1

14.6

M01AX17

ATC

nimesulide; oral

1.5

14.6

537

3824

J01AA07

ATC

tetracycline; systemic

1.5

14.6

469

3249

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

6.4

14.6

L29.0

ICD-10 Finland

Pruritus ani

3.9

14.5

109

D07BC01

ATC

betamethasone and antiseptics; topical

1.7

14.5

300

1872

J04BA02

ATC

dapsone; oral

5.4

14.5

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.8

14.4

244

1440

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

3.7

14.4

123

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

14.4

2167

19514

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.0

14.4

149

750

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.0

14.4

155

792

M03AX01

ATC

botulinum toxin; parenteral

2.9

14.3

236

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

14.2

501

3536

X58

ICD-10 Finland

Exposure to other specified factors

1.5

14.2

429

2930

E000003, ,

ATC

2.1

14.2

133

645

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

14.2

274

1678

N76.0

ICD-10 Finland

Acute vaginitis

1.7

14.2

282

1741

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.5

14.1

365

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.8

14.1

234

1375

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

14.0

750

5729

WX290

NOMESCO Finland

Other blockage of nerve

1.3

13.9

1518

12973

D11AH01

ATC

tacrolimus; topical

3.6

13.9

131

D06BX01

ATC

metronidazole; topical

1.6

13.9

328

2115

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

13.9

755

5780

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.6

13.9

320

J01MA14

ATC

moxifloxacin; systemic

1.8

13.9

220

1275

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

13.8

390

2622

R03BC03

ATC

nedocromil; inhalant

1.9

13.8

188

1040

OAB93, ,

SPAT

1.7

13.8

264

1614

A01

ICPC

Pain general/multiple sites

1.7

13.6

284

1774

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

13.6

1301

10889

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.0

13.6

146

745

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.8

13.6

205

1170

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

13.6

381

2558

SPAT1211

SPAT

Application of soft bandage

1.8

13.5

223

1307

SPAT1058

SPAT

PEF monitoring instruction

1.8

13.5

208

1195

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.5

13.5

472

3324

L15

ICPC

Knee symptom/complaint

1.4

13.5

702

5330

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.2

13.5

115

538

L20

ICD-10 Finland

Atopic dermatitis

2.1

13.4

121

578

D02

ICPC

Abdominal pain epigastric

1.8

13.4

196

1108

N05CF01

ATC

zopiclone; oral

1.4

13.3

778

6021

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

13.3

750

5770

K02.1

ICD-10 Finland

Caries of dentine

1.3

13.3

1804

15872

R01AD05

ATC

budesonide; nasal

1.8

13.3

222

1306

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

2.5

13.3

321

N01

ICPC

Headache

1.5

13.3

409

2804

R52.0

ICD-10 Finland

Acute pain

2.2

13.2

117

555

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.6

13.2

295

1876

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

13.1

276

1730

D11AH02

ATC

pimecrolimus; topical

4.8

13.1

UJF92

NOMESCO Finland

Capsular endoscopy

2.7

13.1

265

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

13.0

2097

18900

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

13.0

608

4526

L56.4

ICD-10 Finland

Polymorphous light eruption

5.2

13.0

C09CA06

ATC

candesartan; oral

1.4

12.9

624

4669

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

12.9

587

4345

J01AA04

ATC

lymecycline; systemic

1.5

12.9

411

2837

XKC03

NOMESCO Finland

Water cystometry

2.5

12.9

314

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

12.8

282

1787

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.1

12.8

115

550

J30.0

ICD-10 Finland

Vasomotor rhinitis

2.4

12.7

364

N05AH04

ATC

quetiapine; oral

1.5

12.7

518

3755

M54.3

ICD-10 Finland

Sciatica

1.9

12.7

168

921

G04BD08

ATC

solifenacin; oral

2.0

12.7

141

729

A01AB04

ATC

amphotericin B; local oral

2.2

12.6

110

519

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

2.8

12.6

230

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

12.6

1019

8292

TLC02

NOMESCO Finland

Simple extraction of IUD

1.9

12.5

163

888

N06AB04

ATC

citalopram; systemic

1.4

12.5

555

4086

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.8

12.5

179

1005

J32.4

ICD-10 Finland

Chronic pansinusitis

3.0

12.5

187

70891

ICD-8 Finland

Urticaria, Recidivans, Chronica

+∞

12.5

C07AB02

ATC

metoprolol; systemic

1.5

12.5

389

2670

SPAT1210

SPAT

Application of cast or individual aid

2.1

12.5

117

568

J01FA15

ATC

telithromycin; oral

1.6

12.3

276

1755

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

12.3

1175

9785

N05CF02

ATC

zolpidem; oral

1.5

12.3

476

3418

S87

ICPC

Dermatitis/atopic eczema

2.3

12.2

396

N03AE01

ATC

clonazepam; systemic

1.9

12.2

147

781

K80

ICPC

Cardiac arrhythmia NOS

1.7

12.2

222

1339

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.7

12.1

255

1598

C05AA08

ATC

fluocortolone; rectal, topical

1.6

12.0

330

2202

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

12.0

532

3913

U07

ICPC

Urine symptom/complaint other

1.7

12.0

217

1304

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

12.0

202

1190

R07.3

ICD-10 Finland

Other chest pain

1.6

12.0

271

1727

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.4

11.9

332

N06AX12

ATC

bupropion; oral

1.6

11.9

256

1613

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.1

11.9

107

512

K03.80

ICD-10 Finland

Irradiated enamel

1.7

11.8

199

1173

-, ,

ICD-10 Finland

2.8

11.8

210

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

11.8

373

2568

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

11.8

301

1976

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.7

11.8

198

1167

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

11.8

638

4864

OAB50, ,

SPAT

1.8

11.7

195

1145

R51.81

ICD-10 Finland

Facial pain NOS

2.3

11.7

372

D06

ICPC

Abdominal pain localized other

1.6

11.7

276

1778

JN3AD

NOMESCO Finland

Abdominal CT examination

1.6

11.7

322

2152

SPAT1238

SPAT

Brief therapy

2.6

11.7

269

R03DC01

ATC

zafirlukast; oral

3.2

11.7

147

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.9

11.6

146

787

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.3

11.6

386

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

11.6

417

2948

J01CA04

ATC

amoxicillin; systemic

1.4

11.6

2450

22779

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.6

11.6

246

1545

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.8

11.5

173

986

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.2

11.5

426

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

3.3

11.5

133

L21.0

ICD-10 Finland

Seborrhoea capitis

3.6

11.4

104

ZXD05

NOMESCO Finland

Urgent procedure

1.4

11.4

798

6331

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.7

11.4

214

J34.2

ICD-10 Finland

Deviated nasal septum

1.9

11.4

134

707

L04AX01

ATC

azathioprine; systemic

2.0

11.4

116

582

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

11.3

426

3036

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.4

11.3

315

S21

ICPC

Skin texture symptom/complaint

1.5

11.3

398

2801

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.0

11.3

114

570

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

11.2

186

1092

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.8

11.2

159

891

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.6

11.2

239

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

11.2

395

2780

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.0

11.2

113

565

N04BC05

ATC

pramipexole; oral

1.8

11.2

177

1026

G43

ICD-10 Finland

Migraine

1.7

11.1

216

1325

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.6

11.1

253

1616

KMAK, ,

NOMESCO Finland

1.3

11.1

1516

13198

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

11.1

564

4249

M25.2

ICD-10 Finland

Flail joint

3.0

11.1

157

E66.01

ICD-10 Finland

Obesity due to excess calories

1.5

11.1

317

2136

L13

ICPC

Hip symptom/complaint

1.4

11.1

481

3524

SPAT1097

SPAT

Recording of ECG

1.6

11.1

301

2005

K11.2

ICD-10 Finland

Sialoadenitis

2.1

11.0

473

H57.1

ICD-10 Finland

Ocular pain

1.9

11.0

131

693

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.6

11.0

302

2014

T78.0

ICD-10 Finland

Anaphylactic shock due to adverse food reaction

11.2

11.0

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

2.4

11.0

313

EB1VA, ,

NOMESCO Finland

1.4

11.0

525

3909

J02AC02

ATC

itraconazole; systemic

1.4

11.0

464

3379

BEF00, ,

SPAT

4.3

11.0

R68.2

ICD-10 Finland

Dry mouth, unspecified

4.3

11.0

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

11.0

650

5019

GD1AA, ,

SPAT

1.4

11.0

515

3823

A03

ICPC

Fever

1.4

11.0

546

4095

L02

ICPC

Back symptom/complaint

1.5

11.0

327

2221

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

11.0

175

1016

J01DA06

ATC

[U] cefuroxime

1.5

10.9

377

2641

R52.1

ICD-10 Finland

Chronic intractable pain

3.5

10.9

103

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.6

10.8

226

N06AX26

ATC

vortioxetine; oral

1.6

10.8

250

1603

R35

ICD-10 Finland

Polyuria

1.9

10.7

144

793

J01

ICD-10 Finland

Acute sinusitis

1.7

10.7

196

1183

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

3.2

10.7

134

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.7

10.7

179

1055

B07.9

ICD-10 Finland

Verruca simplex

2.0

10.6

112

569

R39.1

ICD-10 Finland

Other difficulties with micturition

2.5

10.6

270

R01AD59

ATC

mometasone, combinations; nasal

1.6

10.6

235

1492

R05FB02

ATC

cough suppressants and expectorants; systemic

1.3

10.6

890

7244

C10AC01

ATC

colestyramine; oral

2.3

10.6

357

WX320

NOMESCO Finland

Spinalanesthesy

1.4

10.5

594

4548

M48.0

ICD-10 Finland

Spinal stenosis

1.6

10.5

237

1509

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

10.5

1623

14313

A07EA06

ATC

budesonide; oral, local oral

2.0

10.5

107

537

WZA10

NOMESCO Finland

Extensive medical or dental certificate

2.9

10.5

162

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.8

10.5

142

785

WX780

NOMESCO Finland

Remote monitoring CPAP

1.9

10.5

120

628

WZC00, ,

SPAT

1.4

10.4

417

3005

WYA10

NOMESCO Finland

Emergency care or similar visit

1.7

10.4

216

1347

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.4

10.4

315

N06AB05

ATC

paroxetine; oral

1.7

10.4

173

1017

Z3226

NOMESCO Finland

Physiotherapist

1.4

10.4

437

3181

SPAT1101

SPAT

Orthostatic test

2.3

10.4

341

R09

ICPC

Sinus symptom/complaint

1.6

10.3

281

1871

M23.8

ICD-10 Finland

Other internal derangements of knee

2.0

10.3

115

596

N30.0

ICD-10 Finland

Acute cystitis

1.4

10.3

513

3846

S01XA18

ATC

ciclosporin; ophthalmic

3.7

10.2

A01AB10

ATC

natamycin; local oral

2.2

10.2

408

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.7

10.2

204

M54.8

ICD-10 Finland

Other dorsalgia

1.8

10.1

141

786

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.6

10.1

254

1660

N02AJ13

ATC

tramadol and paracetamol; systemic

2.4

10.1

282

R06.5

ICD-10 Finland

Mouth breathing

1.6

10.1

225

1429

SFA30

NOMESCO Finland

Three-surface restoration

1.3

10.1

1150

9737

R10.0

ICD-10 Finland

Acute abdomen

2.1

10.1

470

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

10.1

1025

8550

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

10.0

196

1204

R06.2

ICD-10 Finland

Wheezing

1.9

10.0

127

687

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.5

10.0

307

2097

XX9TE

NOMESCO Finland

Compementary ultrasound examination

4.0

10.0

L86

ICPC

Back syndrome with radiating pain

1.7

10.0

168

990

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

10.0

1154

9783

G54.0

ICD-10 Finland

Brachial plexus disorders

2.1

10.0

438

J01MA06

ATC

norfloxacin; oral

1.5

10.0

329

2282

J01DC02

ATC

cefuroxime; systemic

1.8

10.0

154

886

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

10.0

787

6337

N06AB10

ATC

escitalopram; oral

1.4

10.0

639

4989

L24.9

ICD-10 Finland

Irritant contact dermatitis, unspecified cause

4.1

10.0

G50.0

ICD-10 Finland

Trigeminal neuralgia

2.6

10.0

224

WX723

NOMESCO Finland

CPAP therapy

1.9

9.9

117

618

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

2.5

9.9

242

B02AA02

ATC

tranexamic acid; systemic

1.4

9.9

469

3483

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.7

9.9

194

1193

Z00.8

ICD-10 Finland

Other general examinations

1.6

9.9

222

1413

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.0

9.9

112

584

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.5

9.9

370

2633

K10.3

ICD-10 Finland

Alveolitis of jaws

1.8

9.9

158

919

H93.1

ICD-10 Finland

Tinnitus

1.7

9.9

180

1086

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.6

9.9

205

1280

M01AH02

ATC

rofecoxib; oral

1.6

9.8

260

1720

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

5.2

9.8

R49.01

ICD-10 Finland

Functional dysphonia

2.1

9.8

441

R11

ICD-10 Finland

Nausea and vomiting

1.6

9.8

248

1624

DHB50

NOMESCO Finland

Turbinoplasty

2.2

9.7

370

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.9

9.7

130

716

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.5

9.7

271

1814

C10AA03

ATC

pravastatin; oral

1.9

9.7

124

673

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.9

9.7

117

623

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

9.7

168

999

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.3

9.7

300

1220

FHL

Arthroscopy

2.1

9.6

451

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.1

9.6

431

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.5

9.6

301

2065

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

9.6

254

1680

L18

ICPC

Muscle pain

1.9

9.6

121

654

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

2.3

9.6

321

ZYY79

NOMESCO Finland

Other indirect service without contact with patient

4.4

9.5

S02.51

ICD-10 Finland

Fracture of tooth, open

1.6

9.5

249

1643

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.8

9.5

150

869

L85.81

ICD-10 Finland

Keratosis pilaris

9.1

9.5

JAH01

NOMESCO Finland

Laparoscopy

1.8

9.5

138

780

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

9.5

363

2593

J01MA01

ATC

ofloxacin; systemic

1.7

9.5

173

1044

S80.0

ICD-10 Finland

Contusion of knee

1.6

9.5

233

1516

F01

ICPC

Eye pain

2.1

9.4

448

A06AC51

ATC

ispaghula, combinations; oral

1.9

9.4

121

658

M35.7

ICD-10 Finland

Hypermobility syndrome

2.4

9.4

267

KH1AD

NOMESCO Finland

CT of urinary organs

2.1

9.4

422

SPAT1229

SPAT

Assessment of need for aid

1.8

9.3

147

852

L23.1

ICD-10 Finland

Allergic contact dermatitis due to adhesives

4.9

9.3

J01CA08

ATC

pivmecillinam; oral

1.3

9.3

1300

11261

S01GX02

ATC

levocabastine; ophthalmic

1.7

9.2

174

1059

N30.9

ICD-10 Finland

Cystitis, unspecified

1.7

9.2

178

1090

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.3

9.2

307

NF1AA

NOMESCO Finland

Hip X-ray examination

1.7

9.2

175

1068

SAA04

NOMESCO Finland

Special examination of mouth

1.8

9.2

145

840

L43.8

ICD-10 Finland

Other lichen planus

2.7

9.2

186

K04

ICPC

Palpitations/awareness of heart

1.7

9.2

151

886

-1, ,

ICD-10 Finland

1.7

9.2

166

1000

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.1

9.2

386

E000004, ,

ATC

2.4

9.2

258

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.6

9.1

203

1289

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.0

9.1

481

B01AB05

ATC

enoxaparin; parenteral

1.3

9.1

730

5879

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.5

9.1

273

1856

N05BA01

ATC

diazepam; systemic, rectal

1.5

9.1

307

2139

SPAT1139

SPAT

Nutrition survey

2.1

9.1

394

N30

ICD-10 Finland

Cystitis

1.5

9.1

268

1817

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.8

9.1

129

725

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

9.1

465

3499

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.5

9.0

329

2327

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.5

9.0

336

2389

D01AE15

ATC

terbinafine; topical

1.7

9.0

148

869

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

9.0

278

1904

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

9.0

443

3312

SPAT1254

SPAT

Administration of medicine

1.5

8.9

336

2391

SCA01

NOMESCO Finland

Preventive oral health care, short

1.3

8.9

879

7275

B35.3

ICD-10 Finland

Tinea pedis

1.8

8.9

128

721

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

2.3

8.9

286

A04

ICPC

Weakness/tiredness general

1.4

8.9

437

3262

R55

ICD-10 Finland

Syncope and collapse

1.6

8.9

223

1457

R30.9

ICD-10 Finland

Painful micturition, unspecified

3.5

8.9

A02BA04

ATC

nizatidine; systemic

1.7

8.9

144

841

G01AF04

ATC

miconazole; vaginal

1.8

8.9

142

826

D93

ICPC

Irritable bowel syndrome

2.6

8.9

201

J35.0

ICD-10 Finland

Chronic tonsillitis

1.6

8.9

187

1172

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

8.9

291

2016

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.7

8.9

178

N94.5

ICD-10 Finland

Secondary dysmenorrhoea

2.2

8.9

358

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.2

8.9

345

SAD02

NOMESCO Finland

Assessment of need for oral health care, extensive

1.8

8.8

141

820

R74

ICPC

Upper respiratory infection acute

1.3

8.8

1092

9299

A46

ICD-10 Finland

Erysipelas

1.5

8.8

281

1935

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

8.8

783

6391

E0001A1, ,

ATC

2.2

8.8

313

F41.09

ICD-10 Finland

UNS Panic Syndrome

1.9

8.8

103

544

-1, ,

NOMESCO Finland

1.3

8.8

968

8126

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.8

8.8

124

696

L56.3

ICD-10 Finland

Solar urticaria

9.5

8.8

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.6

8.8

224

1471

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.5

8.7

288

1997

ZX112

NOMESCO Finland

Subcutaneous

2.4

8.7

245

R25.2

ICD-10 Finland

Cramp and spasm

2.2

8.7

308

H01.80

ICD-10 Finland

Prolonged inflammation in the edge of the eyelid

3.5

8.6

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.5

8.6

222

L83

ICPC

Neck syndrome

3.2

8.6

104

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.9

8.6

520

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

8.6

268

1839

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.7

8.5

165

1012

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

8.5

517

3994

N02AA05

ATC

oxycodone; systemic

1.4

8.5

342

2465

C03CA01

ATC

furosemide; systemic

1.4

8.5

482

3684

SPAT1262

SPAT

Handing over of treatment supplies

1.4

8.5

349

2526

G03DC03

ATC

lynestrenol; oral

2.1

8.5

378

R76.0

ICD-10 Finland

Raised antibody titre

6.4

8.5

XQ832

NOMESCO Finland

Other provocation test

20.1

8.5

T82

ICPC

Obesity

1.8

8.4

135

786

S99

ICPC

Skin disease other

2.4

8.4

249

J01.1

ICD-10 Finland

Acute frontal sinusitis

2.4

8.4

249

G04CA02

ATC

tamsulosin; oral

1.5

8.4

263

1804

A07EA02

ATC

hydrocortisone; rectal

2.4

8.4

237

R06AX18

ATC

acrivastine; oral

2.1

8.4

359

ZYY98

NOMESCO Finland

Missed treatment contact, no notification given by patient

4.7

8.3

7080A

ICD-9 Finland

Urticaria, Allergic urticaria

+∞

8.3

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.2

8.3

334

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

1.9

8.3

104

562

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.7

8.3

150

904

M01AH03

ATC

valdecoxib; oral

1.8

8.3

131

761

A03CA02

ATC

clidinium and psycholeptics; oral

1.8

8.3

113

628

G01AF05

ATC

econazole; vaginal

1.5

8.3

232

1556

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

8.3

257

1762

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.6

8.2

194

1250

L81.4

ICD-10 Finland

Other melanin hyperpigmentation

3.5

8.2

L60.0

ICD-10 Finland

Ingrowing nail

1.7

8.2

135

792

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

2.1

8.2

336

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.6

8.2

212

1396

L14

ICPC

Leg/thigh symptom/complaint

1.6

8.2

203

1324

N06AB06

ATC

sertraline; oral

1.4

8.2

340

2465

M01AX05

ATC

glucosamine; oral

1.4

8.2

352

2569

XQ845

NOMESCO Finland

Dermatoscopy

2.6

8.2

186

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

2.5

8.1

192

N03AX11

ATC

topiramate; oral

2.0

8.1

425

L28

ICD-10 Finland

Lichen simplex chronicus and prurigo

3.6

8.1

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.3

8.1

260

SCA02

NOMESCO Finland

Preventive oral health care

1.5

8.1

305

2171

R49.09

ICD-10 Finland

Unspecified dysphonia

3.0

8.1

119

R03BB01

ATC

ipratropium bromide; inhalant

2.2

8.1

312

H53.9

ICD-10 Finland

Visual disturbance, unspecified

1.9

8.1

101

546

WX002

NOMESCO Finland

Sedation and analgesia

1.4

8.1

417

3139

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

2.3

8.1

242

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

3.0

8.0

114

L95.8

ICD-10 Finland

Other vasculitis limited to skin

8.9

8.0

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.3

8.0

255

R03AK11

ATC

formoterol and fluticasone; inhalant

2.1

8.0

346

J04.0

ICD-10 Finland

Acute laryngitis

1.7

8.0

128

746

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.4

8.0

342

2494

R4180

NOMESCO Finland

Podiatric therapy

2.9

8.0

120

H92.0

ICD-10 Finland

Otalgia

1.6

7.9

197

1285

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.3

7.9

794

6568

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

7.9

316

2273

K29.7

ICD-10 Finland

Gastritis, unspecified

2.0

7.9

436

F45.0

ICD-10 Finland

Somatization disorder

4.3

7.9

M02AA10

ATC

ketoprofen; topical

1.4

7.9

360

2651

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.5

7.9

211

1400

D06AX01

ATC

fusidic acid; topical

1.5

7.9

238

1621

M54.1

ICD-10 Finland

Radiculopathy

1.8

7.9

105

579

M01AB08

ATC

etodolac; oral

1.6

7.9

168

1058

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.8

7.8

118

676

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

7.8

474

3658

H60

ICD-10 Finland

Otitis externa

1.6

7.8

158

981

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

3.2

7.8

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.2

7.8

271

WIX00

NOMESCO Finland

Allergy cleanup guidance

10.8

7.8

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

7.8

144

874

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.8

7.8

112

633

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.7

7.8

136

813

H81.3

ICD-10 Finland

Other peripheral vertigo

2.1

7.7

324

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

2.3

7.7

240

WX204

NOMESCO Finland

Axillary plexus blockaced

2.0

7.7

426

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

1.9

7.7

454

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.2

7.7

272

M22.4

ICD-10 Finland

Chondromalacia patellae

1.9

7.7

511

N02CC04

ATC

rizatriptan; oral

1.6

7.7

189

1230

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

2.9

7.7

117

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

2.9

7.7

117

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.3

7.7

260

U02

ICPC

Urinary frequency/urgency

1.4

7.7

402

3033

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

3.4

7.7

WXQ12

NOMESCO Finland

Psoralen - Ultraviolet A therapy with local sensitivisation

4.5

7.6

N17

ICPC

Vertigo/dizziness

1.4

7.6

307

2212

N06AX03

ATC

mianserin; oral

1.8

7.6

110

622

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.7

7.6

138

833

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.3

7.6

242

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

3.6

7.6

ZY010

NOMESCO Finland

Hospital outpatient

1.6

7.6

155

966

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

7.6

644

5214

EMB10

NOMESCO Finland

Tonsillectomy

1.6

7.6

188

1228

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.4

7.5

299

2149

SCA03

NOMESCO Finland

Preventive oral health care, extensive

1.7

7.5

139

843

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

2.4

7.5

218

K05.09

ICD-10 Finland

Acute gingivitis, UNS

2.3

7.5

231

N63

ICD-10 Finland

Unspecified lump in breast

1.5

7.5

213

1434

P01

ICPC

Feeling anxious/nervous/tense

1.3

7.5

457

3532

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

7.4

232

1592

K59.0

ICD-10 Finland

Constipation

1.7

7.4

129

770

L04AA13

ATC

[U] leflunomide

2.2

7.4

290

A07EC02

ATC

mesalazine; oral, rectal

1.7

7.4

131

786

D11

ICPC

Diarrhoea

1.4

7.4

358

2665

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

7.4

841

7061

LCA06

NOMESCO Finland

Biopsy of endometrium

1.4

7.4

348

2580

D10AX03

ATC

azelaic acid; topical

1.5

7.4

247

1720

ACC51

NOMESCO Finland

Release of median nerve

1.5

7.4

193

1276

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.4

7.4

272

1930

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.6

7.4

151

942

M77.1

ICD-10 Finland

Lateral epicondylitis

1.5

7.3

233

1604

D05BB02

ATC

acitretin; oral

2.4

7.3

196

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

2.1

7.3

338

A06AD11

ATC

lactulose; oral

1.4

7.3

271

1923

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

2.2

7.3

272

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

2.8

7.3

126

7088B

ICD-9 Finland

Urticaria, Other specified urticaria[URTICARIA RECURRENS NUD]

+∞

7.3

7088A

ICD-9 Finland

Urticaria, Other specified urticaria[URTICARIA CHRONICA NUD]

+∞

7.3

L16

ICPC

Ankle symptom/complaint

1.4

7.3

340

2516

WQ000

NOMESCO Finland

Hyposensibilisation

3.3

7.2

X57

ICD-10 Finland

Unspecified privation

2.2

7.2

254

R4110, ,

SPAT

1.4

7.2

324

2380

SPAT1240

SPAT

Therapeutic discussion

1.4

7.2

325

2389

I84.4

ICD-10 Finland

External hemorrhoids with other complications

2.8

7.2

127

M43.1

ICD-10 Finland

Spondylolisthesis

1.8

7.2

523

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.5

7.2

195

1299

J05AB11

ATC

valaciclovir; oral

1.4

7.2

382

2887

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.6

7.2

155

980

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

7.1

160

1020

N06AA10

ATC

nortriptyline; systemic

2.2

7.1

275

N28.1

ICD-10 Finland

Cyst of kidney

2.9

7.1

106

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.5

7.1

228

1574

I73.0

ICD-10 Finland

Raynaud syndrome

2.2

7.1

250

L13.0

ICD-10 Finland

Dermatitis herpetiformis

5.6

7.1

F32.1

ICD-10 Finland

Moderate depressive episode

1.5

7.0

202

1362

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

1.8

7.0

110

638

SPAT1307

SPAT

Psychosocial counselling and guidance

1.5

7.0

203

1371

A98

ICPC

Health maint/preventive medicine

1.9

7.0

2940

28774

N89

ICPC

Migraine

1.7

7.0

137

845

TAB00

NOMESCO Finland

Lumbar puncture

1.7

7.0

119

707

H60.8

ICD-10 Finland

Other otitis externa

1.9

7.0

478

A02BA03

ATC

famotidine; systemic

2.1

7.0

311

J39.9

ICD-10 Finland

Disease of upper respiratory tract, unspecified

3.3

7.0

JF1BD

NOMESCO Finland

Very extensive small bowel CT

4.4

7.0

C01DA14

ATC

isosorbide mononitrate; oral

1.5

6.9

189

1260

N06BA04

ATC

methylphenidate; oral

1.7

6.9

122

731

M15

ICD-10 Finland

Polyarthrosis

1.7

6.9

115

678

K50.9

ICD-10 Finland

Crohn disease, unspecified

2.5

6.9

177

C08CA01

ATC

amlodipine; oral

1.3

6.9

725

6018

K05.0

ICD-10 Finland

Acute gingivitis

2.0

6.9

360

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.6

6.9

140

872

ZXH09

NOMESCO Finland

Procedure performed in other unit outside usual setting for the procedure

3.6

6.9

SBA10

NOMESCO Finland

Measurement of salivary flow rate

2.7

6.9

125

N41.9

ICD-10 Finland

Inflammatory disease of prostate, unspecified

3.5

6.8

H10

ICD-10 Finland

Conjunctivitis

1.5

6.8

227

1579

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

6.8

555

Z00.0

ICD-10 Finland

General medical examination

1.3

6.8

471

3704

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

6.8

397

ZX120

NOMESCO Finland

Intravenous

1.5

6.8

204

1390

SGA01

NOMESCO Finland

Emergency treatment

1.3

6.8

470

3696

H02

ICPC

Hearing complaint

1.4

6.8

282

2045

D10BA01

ATC

isotretinoin; oral

1.5

6.8

206

1407

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.6

6.8

140

876

L21

ICD-10 Finland

Seborrhoeic dermatitis

2.3

6.7

223

L66.9

ICD-10 Finland

Cicatricial alopecia, unspecified

16.7

6.7

XQ818

NOMESCO Finland

Conjunctival allergen provocation test

16.7

6.7

R03DA04

ATC

theophylline; systemic, rectal

1.8

6.7

484

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

6.7

1237

10922

L57.0

ICD-10 Finland

Actinic keratosis

1.5

6.7

178

1181

3007

Kela drug reimbursment

Erenumab and fremanezumab

2.2

6.7

243

L04

ICPC

Chest symptom/complaint

1.6

6.7

165

1077

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.5

6.7

185

1239

Z20.2

ICD-10 Finland

Contact with and exposure to infections with a predominantly sexual mode of transmission

1.9

6.7

435

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

2.2

6.7

250

DJD20

NOMESCO Finland

Plastic repair of septum of nose

1.9

6.7

428

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.6

6.7

154

990

SPAT1283

SPAT

Restricted health certificate

1.3

6.7

572

4630

S06

ICPC

Rash localized

1.7

6.6

129

794

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

1.5

6.6

224

1562

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

2.4

6.6

187

N77.1*B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

1.9

6.6

422

N03AF02

ATC

oxcarbazepine; oral

1.9

6.6

422

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.4

6.6

276

2003

K13.78

ICD-10 Finland

Other change in the oral mucosa

2.0

6.6

352

G44.8

ICD-10 Finland

Other specified headache syndromes

2.2

6.6

251

D72.1

ICD-10 Finland

Eosinophilia

5.5

6.6

L01BA01

ATC

methotrexate; systemic

1.8

6.6

473

M89.0

ICD-10 Finland

Algoneurodystrophy

2.8

6.6

111

DM1AA, ,

SPAT

2.1

6.6

278

S63.5

ICD-10 Finland

Sprain and strain of wrist

1.7

6.6

113

674

M77.4

ICD-10 Finland

Metatarsalgia

1.5

6.5

174

1155

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.5

6.5

188

1269

SPAT1377

SPAT

Polysomnography

1.9

6.5

431

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

2.8

6.5

106

S01GX08

ATC

ketotifen; ophthalmic

1.6

6.5

140

885

I47.1

ICD-10 Finland

Supraventricular tachycardia

1.8

6.5

100

578

ZXA05

NOMESCO Finland

Left side

1.3

6.5

493

3925

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.8

6.5

534

Y89.9

ICD-10 Finland

Sequelae of unspecified external cause

2.8

6.5

112

N94.1

ICD-10 Finland

Dyspareunia

2.1

6.5

273

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.5

6.5

199

1363

J33.0

ICD-10 Finland

Polyp of nasal cavity

2.0

6.4

307

T88.6

ICD-10 Finland

Anaphylactic shock due to adverse effect of correct drug or medicament properly administered

5.7

6.4

D07XB05

ATC

dexamethasone; topical

2.0

6.4

314

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.6

6.4

130

809

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

2.8

6.4

107

Z2445

NOMESCO Finland

Psychologist

1.7

6.4

108

641

K03.00

ICD-10 Finland

Approximal wear

1.5

6.4

214

1491

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

3.0

6.4

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.4

6.3

254

1830

Z71.8

ICD-10 Finland

Other specified counselling

1.2

6.3

972

8408

K50.0

ICD-10 Finland

Crohn disease of small intestine

2.3

6.3

185

C08CA13

ATC

lercanidipine; oral

1.4

6.3

269

1959

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.6

6.3

151

979

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.1

6.3

276

D11AH05

ATC

dupilumab; topical

5.5

6.3

NDF25

NOMESCO Finland

Operation for osteochondritis of joint of wrist, arthroscopic

3.2

6.3

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

1.9

6.3

401

U01

ICPC

Dysuria/painful urination

1.5

6.3

225

1588

S50.0

ICD-10 Finland

Contusion of elbow

1.8

6.3

495

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.4

6.3

266

1936

R10.2

ICD-10 Finland

Pelvic and perineal pain

1.9

6.3

366

N03AF01

ATC

carbamazepine; oral, rectal

1.7

6.3

106

630

WXQ26

NOMESCO Finland

UVB broad spectrum light therapy

+∞

6.3

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.5

6.2

159

1046

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.4

6.2

248

1785

M01AB55

ATC

diclofenac, combinations; oral

1.6

6.2

126

785

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.0

6.2

346

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.3

6.2

364

2792

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.6

6.2

127

793

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

1.7

6.2

117

716

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.6

6.2

126

786

E66.8

ICD-10 Finland

Other obesity

1.5

6.2

168

1121

L82

ICD-10 Finland

Seborrhoeic keratosis

1.3

6.2

420

3292

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

1.9

6.2

389

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

1.7

6.2

107

640

W19

ICD-10 Finland

Unspecified fall

1.5

6.2

212

1485

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

3.2

6.1

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.0

6.1

306

SPAT1281

SPAT

Other administrative function

1.5

6.1

181

1229

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

6.1

484

SFA00

NOMESCO Finland

Small restoration

1.3

6.1

367

2824

N03AX09

ATC

lamotrigine; oral

1.6

6.1

143

922

L28

ICPC

Limited function/disability (L)

1.3

6.1

374

2886

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

2.4

6.1

169

JG1JB

NOMESCO Finland

Defekography with X-ray

3.0

6.1

L87

ICPC

Bursitis/tendinitis/synovitis NOS

2.3

6.1

188

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

2.3

6.1

188

R06AX11

ATC

astemizole; oral

1.8

6.1

441

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.7

6.1

574

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

6.1

575

4705

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

1.9

6.1

398

XPX04

NOMESCO Finland

Angioscopy

4.1

6.1

L98.1

ICD-10 Finland

Factitial dermatitis

12.5

6.1

E03

ICD-10 Finland

Other hypothyroidism

1.5

6.1

164

1093

-54

ICPC

Repair/fix-suture/cast/prosth device

2.2

6.1

227

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.5

6.0

209

1465

AA3AD

NOMESCO Finland

CT of face

3.1

6.0

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.7

6.0

110

667

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.4

6.0

220

1558

O85

ICD-10 Finland

Puerperal sepsis

2.6

6.0

134

AA1CG, ,

SPAT

2.5

6.0

140

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

2.3

6.0

183

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3005322) IgE [Units/volume] in Serum or Plasma

812

2080

4.98

301.24

1.7

1.3

232.61

223.64

u/ml

0.07

776

1935

(3019420) Tryptase [Mass/volume] in Serum or Plasma

159

138

12.11

155.89

1.5

1.6

5.71

8.23

ug/l

0.84

148

121

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

34.43

137.07

1.1

1.0

0.32

0.01

u/ml

0.50

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

116

14.15

125.80

1.2

0.30

0.29

g/l

0.36

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

132

136

10.10

114.91

1.5

17.58

19.90

u/ml

0.18

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

106

13.87

113.78

1.2

1.3

108.55

105.91

0.31

(3037522) Nuclear Ab [Titer] in Serum

885

4245

2.54

107.40

1.6

1.4

488.27

552.95

titre

0.49

179

885

(3001604) Monocytes [#/volume] in Blood

2006

13735

2.38

106.40

7.5

6.3

0.54

0.55

e9/l

1.60

1812

11968

(3006315) Basophils [#/volume] in Blood

2008

13757

2.38

106.32

7.5

6.3

0.04

e9/l

0.99

1814

11979

(3013115) Eosinophils [#/volume] in Blood

2053

14219

2.39

105.71

7.7

6.5

0.20

0.18

e9/l

6.18

1894

12593

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

119

123

10.03

103.28

1.6

1.3

59.09

69.00

titre

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

119

125

9.87

102.07

1.6

1.4

883.75

817.00

titre

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

319

875

3.96

102.06

1.7

1.9

1.19

1.18

g/l

0.24

301

831

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

312

845

4.00

101.60

1.7

2.0

0.23

g/l

0.08

293

802

(3019198) Lymphocytes [#/volume] in Blood

2027

14099

2.34

101.16

7.6

6.3

1.97

1.95

e9/l

0.15

1866

12601

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

2536

19591

2.86

99.57

5.8

4.2

10.16

10.65

mm/h

1.27

2413

18508

(40760892) CBC W Ordered Manual Differential panel - Blood

1156

6691

2.18

87.17

5.4

4.5

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2098

15332

2.21

85.09

9.6

9.4

4.00

e9/l

0.00

1884

13411

(40768443) Skin Pathology biopsy report

335

1085

3.35

82.95

1.3

1.2

—

(3021589) Normoblasts [#/volume] in Blood

1745

12047

2.07

79.96

13.1

10.4

0.00

e9/l

0.35

1488

9869

(3019069) Monocytes/Leukocytes in Blood

1789

12592

2.04

76.10

7.8

6.4

8.23

8.49

4.42

1714

11845

(3006504) Eosinophils/Leukocytes in Blood

1784

12569

2.03

75.37

7.7

6.3

3.05

2.78

5.20

1706

11804

(3022096) Basophils/Leukocytes in Blood

1781

12567

2.02

74.59

7.8

6.4

0.68

0.69

0.28

1703

11779

(3002030) Lymphocytes/Leukocytes in Blood

1819

13025

2.00

71.91

7.7

6.3

29.15

28.93

0.46

1754

12388

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2430

19511

2.27

68.39

9.4

7.8

73.64

75.91

u/l

2.44

2329

18591

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1816

13162

1.96

67.29

6.1

6.3

9.87

10.57

umol/l

2.98

1715

12545

(40761536) Microorganisms panel - Urine sediment

496

2223

2.47

66.25

4.7

3.7

—

(3018010) Neutrophils/Leukocytes in Blood

1764

12790

1.92

63.78

7.5

6.2

56.22

56.69

1.09

1717

12254

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

129

251

5.32

63.07

1.3

1.2

1.55

1.99

u/ml

0.17

119

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2627

22037

2.50

62.89

6.0

4.7

14.58

14.51

pmol/l

0.74

2467

20623

(3021601) Nitrite [Presence] in Urine by Test strip

1920

14357

1.93

62.69

4.8

3.7

0.00

estimate

0.27

552

2999

(3009261) Glucose [Presence] in Urine by Test strip

1935

14599

1.91

60.35

4.9

3.7

1.88

0.11

estimate

0.46

535

2918

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1165

7478

1.91

60.32

1.5

1.3

1.14

1.48

u/ml

0.73

369

2148

(3015171) Extractable nuclear Ab [Units/volume] in Serum

323

1228

2.83

59.86

1.3

3.02

0.92

u/ml

0.55

(3035350) Ketones [Presence] in Urine by Test strip

1922

14498

1.90

59.64

4.9

3.7

6.91

4.08

estimate

0.24

555

3059

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1552

11067

1.83

56.28

4.6

3.5

0.03

0.08

estimate

0.51

475

2485

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1125

7272

1.87

55.96

2.5

2.1

125.75

172.51

u/l

3.44

1061

6931

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

951

5837

1.92

55.41

1.5

1.3

29.55

26.33

iu/ml

0.32

313

1744

(3000850) Epithelial cells [#/volume] in Urine

901

5438

1.94

55.18

2.9

2.6

5.99

7.45

e6/l

2.81

823

4947

(3007164) IgA [Mass/volume] in Serum or Plasma

1015

6381

1.89

54.83

1.8

1.4

2.19

2.22

g/l

0.26

684

4135

(3029937) Albumin [Presence] in Urine by Test strip

1183

7816

1.85

54.52

5.1

3.8

0.00

estimate

1.94

537

2867

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

237

801

3.13

54.09

1.2

1.1

1.86

2.37

u/ml

0.34

152

417

(3012494) Peanut IgE Ab [Units/volume] in Serum

8.02

53.72

1.1

0.37

1.93

u/ml

0.97

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1209

8084

1.83

53.26

2.8

2.6

55.43

59.38

u/l

2.13

1112

7553

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

882

5354

1.92

52.65

1.4

1.3

8.81

9.80

u/ml

0.19

390

2210

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

10.02

52.55

1.1

1.0

0.65

10.34

u/ml

0.49

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

514

2588

2.19

51.36

1.3

1.2

148.73

152.16

u/ml

0.05

195

986

(3003888) Timothy IgE Ab [Units/volume] in Serum

214

706

3.19

50.82

1.1

3.12

5.03

u/ml

1.50

126

379

(3036481) Cortisol [Moles/volume] in Serum or Plasma

531

2745

2.13

49.46

2.3

2.1

351.42

379.15

nmol/l

2.90

499

2552

(3031040) Bacteria [#/volume] in Urine by Automated count

2167

17485

1.85

48.71

6.0

4.4

561.29

2181.69

e6/l

2.01

213

(3010726) Horse dander IgE Ab [Units/volume] in Serum

202

673

3.15

47.13

1.2

1.1

1.49

1.53

u/ml

0.03

123

327

(40768797) Stomach Pathology biopsy report

644

3646

1.97

46.47

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

200

680

3.08

45.05

1.1

1.53

0.93

u/ml

0.35

107

283

(3048689) Calprotectin [Mass/mass] in Stool

710

4192

1.91

45.05

3.0

2.4

89.60

107.05

ug/g

1.39

547

3338

(3030467) Casts [#/volume] in Urine by Automated count

1034

6858

1.77

44.90

3.5

3.0

0.23

0.36

e6/l

3.14

799

4934

(3015736) pH of Urine

1555

11566

1.71

44.62

4.0

3.3

6.24

6.22

0.28

924

6680

(36304419) Bacteria [Presence] in Urine

1004

6614

1.78

44.56

3.5

2.9

—

0.37

estimate

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1255

8812

1.73

44.42

3.2

3.3

2.35

mmol/l

0.39

1152

8131

(3005719) IgG [Mass/volume] in Serum or Plasma

427

2121

2.18

43.66

3.0

2.9

10.32

10.58

g/l

0.70

388

1973

(3002582) Erythrocytes [#/volume] in Urine

1156

7968

1.73

43.49

3.7

3.1

99.86

89.72

e6/l

0.09

924

5978

(3023420) DNA double strand Ab [Units/volume] in Serum

295

1253

2.50

43.35

2.0

9.37

7.36

iu/ml

0.32

313

(3024561) Albumin [Mass/volume] in Serum or Plasma

1470

10847

1.69

42.78

5.1

4.8

36.96

36.46

g/l

3.38

1381

10221

(3041096) Erythrocytes [Presence] in Urine by Automated

1177

8183

1.72

42.72

3.9

3.0

1.06

0.15

estimate

0.65

478

2417

(3018418) pH of Serum or Plasma

1072

7277

1.73

42.33

4.1

4.0

7.40

0.10

801

5157

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2802

25139

2.64

42.25

7.2

5.6

1.78

1.81

mu/l

0.50

2659

23794

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

163

5.34

42.21

1.6

1.9

0.57

1.42

u/ml

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1230

8717

1.69

41.16

3.9

3.2

20.17

46.23

ng/l

2.12

660

5077

(3018095) Leukocytes [#/volume] in Urine

1327

9604

1.68

40.96

4.4

3.7

61.40

87.69

e6/l

0.90

981

6471

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2887

26388

3.27

40.31

19.0

13.4

17.23

21.26

mg/l

11.56

2492

21391

(3007853) Bacteria identified in Skin by Aerobe culture

541

3035

1.95

39.44

1.8

1.7

—

(3028026) IgM [Mass/volume] in Serum or Plasma

347

1652

2.24

39.20

2.1

1.8

1.31

1.40

g/l

0.41

323

1540

(3014133) Dog dander IgE Ab [Units/volume] in Serum

174

604

3.00

37.74

1.1

4.61

3.19

u/ml

0.53

295

(3021440) Promyelocytes/Leukocytes in Blood

420

2237

2.02

35.24

4.0

4.7

0.18

0.11

0.55

543

(3019550) Sodium [Moles/volume] in Serum or Plasma

2847

26069

2.68

35.06

18.7

14.7

139.54

139.67

mmol/l

2.30

2817

25573

(3026782) Osmolality of Urine

725

4611

1.75

34.84

3.0

2.8

504.98

522.86

mosm/kgh2o

1.39

633

4054

(3016031) Almond IgE Ab [Units/volume] in Serum

14.05

34.80

1.1

1.0

0.18

0.77

u/ml

—

(44813793) Dust mix specific IgE antibody measurement

230

4.19

34.79

1.1

1.0

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2850

26126

2.69

34.71

18.8

14.8

3.92

3.93

mmol/l

1.45

2816

25574

(3017181) Myelocytes/Leukocytes in Blood

430

2325

1.99

34.54

4.0

4.7

1.18

0.89

0.63

632

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

10.39

34.25

1.0

0.01

0.12

u/ml

0.59

(3002179) Metamyelocytes/Leukocytes in Blood

414

2219

2.00

34.06

4.0

4.5

0.76

0.64

0.17

600

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

427

2316

1.98

33.96

3.6

3.0

—

(3035933) Granulocytes/Leukocytes in Blood

166

596

2.89

33.87

3.6

3.3

56.52

57.77

0.68

166

596

(3023430) Cat dander IgE Ab [Units/volume] in Serum

159

558

2.95

33.81

1.1

4.13

3.65

u/ml

0.13

239

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

10.11

33.62

1.0

0.02

0.06

u/ml

0.75

(3025159) Blasts/Leukocytes in Blood

420

2286

1.97

33.01

4.1

4.9

0.15

0.26

0.24

513

(3013826) Glucose [Moles/volume] in Serum or Plasma

1817

14686

1.60

32.91

5.4

4.7

6.44

6.46

mmol/l

0.10

1725

13683

(3020874) Milk IgE Ab [Units/volume] in Serum

229

4.07

32.45

1.1

1.0

0.42

2.53

u/ml

0.75

(3013139) Helicobacter pylori Ag [Presence] in Stool

376

1986

2.02

32.14

1.3

1.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1829

14880

1.58

31.56

3.9

3.2

95.03

90.41

ug/l

0.37

1712

14125

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

2577

22908

1.87

31.29

20.7

16.4

13.41

13.45

0.78

2556

22603

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1595

12591

1.57

31.28

2.9

2.4

75.82

75.92

nmol/l

0.05

1461

11688

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

354

1857

2.03

30.78

4.1

3.5

1.23

mmol/l

0.30

297

1604

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

987

6998

1.61

30.61

2.0

1.7

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

216

932

2.42

30.45

1.3

34.01

36.76

u/ml

0.06

(3032080) INR in Blood by Coagulation assay

1339

10206

1.56

30.33

12.3

11.1

1.12

1.16

inr

2.88

1142

8418

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

759

5061

1.67

29.99

2.0

1.6

71994111.17

40074211.88

pmol/l

0.48

632

4337

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

9.56

29.74

1.0

0.01

1.01

u/ml

0.50

(3026008) Bacteria identified in Urine by Culture

1082

7888

1.58

29.59

3.4

2.8

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

966

6868

1.60

29.35

2.4

2.2

2.64

2.67

mg/l

0.18

837

5991

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1385

10698

1.55

29.16

6.3

6.1

1.21

mmol/l

0.50

1302

9944

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

170

672

2.62

28.82

1.2

1.3

1.07

3.28

u/ml

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

9.07

28.60

1.0

0.01

u/ml

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

143

519

2.84

28.60

1.1

0.04

0.18

u/ml

1.66

156

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1526

12075

1.53

28.53

6.9

6.7

1.21

1.22

mmol/l

0.34

1272

10510

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

718

4778

1.66

28.35

2.6

2.7

2.43

mmol/l

0.83

640

4282

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

887

6223

1.60

28.28

2.1

1.7

0.68

1.00

mg/l

7.82

649

4731

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

200

867

2.40

27.88

1.3

2.77

8.14

u/ml

1.83

140

(3012095) Magnesium [Moles/volume] in Serum or Plasma

616

3963

1.70

27.57

3.4

3.5

0.83

0.82

mmol/l

0.85

575

3758

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

198

866

2.38

27.05

1.3

4.96

6.95

u/ml

0.20

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

345

1879

1.94

26.79

1.6

1.4

—

(44806420) Estimation of glomerular filtration rate

114

378

3.10

26.78

3.0

2.2

—

(3022948) Iron [Moles/volume] in Serum or Plasma

640

4194

1.67

26.60

2.3

2.4

14.69

14.00

umol/l

1.33

582

3920

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

196

862

2.36

26.44

1.3

1.2

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

594

3833

1.68

26.14

2.3

2.4

2.49

2.40

g/l

4.18

531

3557

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1219

9315

1.52

26.02

3.2

29.94

30.26

u/l

0.08

1144

8848

(3000494) Fungus identified in Specimen by Culture

523

3278

1.72

25.58

1.9

1.4

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2935

27758

3.24

25.32

21.9

16.4

70.92

70.96

umol/l

0.03

2925

27475

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

9.46

25.30

1.0

0.05

0.53

u/ml

0.51

(3020630) Protein [Mass/volume] in Serum or Plasma

316

1707

1.95

25.08

2.4

2.9

67.21

66.93

g/l

0.30

297

1594

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2206

19162

1.57

25.07

3.7

3.2

42.64

39.79

u/l

0.90

2099

18293

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

492

3057

1.73

24.76

2.4

2.7

5.34

7.10

umol/l

2.01

414

2666

(3022145) Colonoscopy Study observation

483

2989

1.73

24.66

1.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

119

425

2.87

24.53

1.5

1.3

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

9.44

24.42

1.0

0.02

2.95

u/ml

0.51

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

543

3486

1.68

24.17

2.4

2.5

24.21

23.60

0.46

496

3249

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

163

687

2.45

24.16

1.2

1.3

—

7.87

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

825

5865

1.56

24.14

2.9

598.79

954.67

ng/l

6.51

686

4898

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

310

1686

1.93

24.08

1.9

1.6

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

228

3.58

23.95

1.1

1.0

0.47

0.90

u/ml

0.56

(3003327) Ova and parasites identified in Stool by Light microscopy

237

1177

2.10

23.73

2.1

1.6

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

2717

25013

1.88

23.34

16.5

12.6

88.46

87.41

ml/min/173m2

1.96

2546

22883

(4062490) Immunoglobulin typing, IgG

285

3.22

22.86

1.8

1.4

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

170

749

2.35

22.83

1.3

1.2

27.50

39.70

u/ml

0.57

(3011841) English Walnut IgE Ab [Units/volume] in Serum

8.60

22.77

1.0

0.21

1.06

u/ml

0.63

(3026493) Urate [Moles/volume] in Serum or Plasma

878

6417

1.52

22.31

2.7

2.4

316.36

318.23

umol/l

0.24

790

5785

(3015076) Soybean IgE Ab [Units/volume] in Serum

213

3.54

21.85

1.1

1.0

0.21

2.01

u/ml

0.53

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2623

23990

1.72

21.80

6.4

5.4

38.09

38.03

mmol/mol

0.16

2507

22772

(3028192) IgG subclass 2 [Mass/volume] in Serum

286

3.14

21.43

1.8

1.4

2.87

2.97

g/l

0.25

205

(3024139) IgG subclass 3 [Mass/volume] in Serum

286

3.14

21.43

1.7

1.4

0.35

0.37

g/l

0.21

205

(3027135) IgG subclass 1 [Mass/volume] in Serum

287

3.13

21.30

1.8

1.4

6.05

6.48

g/l

0.80

207

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2918

27716

2.69

21.08

14.7

10.9

25.28

25.15

u/l

0.18

2860

27082

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1337

10767

1.43

20.15

2.1

2.0

97.60

97.71

pmol/l

0.03

724

5718

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2686

24854

1.75

19.77

5.2

4.5

5.76

5.74

mmol/l

0.33

2497

23259

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

223

1165

1.99

19.40

1.6

10.03

11.82

u/ml

0.29

316

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

224

1173

1.98

19.35

1.6

2.1

42.00

39.59

u/l

1.02

213

1077

(40768804) Tissue Pathology biopsy report

1365

11093

1.42

19.25

2.2

2.0

—

(3025941) Bacteria identified in Stool by Culture

291

1672

1.82

18.92

1.4

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

322

1908

1.77

18.88

1.4

1.3

39.68

46.00

au/ml

—

124

(3024980) IgG subclass 4 [Mass/volume] in Serum

117

476

2.52

18.73

1.9

1.6

0.66

0.70

g/l

0.16

372

(3021960) Folate [Moles/volume] in Serum or Plasma

890

6713

1.46

18.70

1.7

1.6

19.25

20.53

nmol/l

2.03

761

5833

(3012501) Base excess in Blood by calculation

112

447

2.56

18.66

3.9

3.3

1.87

2.37

mmol/l

1.72

290

(3011397) Hemoglobin [Presence] in Urine by Test strip

858

6479

1.45

17.74

4.7

3.6

0.83

0.20

—

(3019309) Folate [Moles/volume] in Red Blood Cells

521

3549

1.57

17.72

1.9

1.7

1318.50

1184.46

nmol/l

2.46

401

2722

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

337

2068

1.71

17.41

2.5

2.4

14.43

19.88

au/ml

1.00

266

(3039162) Centromere protein B Ab [Units/volume] in Serum

381

2.63

17.24

1.2

1.3

32.40

57.78

u/ml

—

(1616796) Gas panel - Central venous blood

115

486

2.42

16.99

3.9

3.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

567

3975

1.53

16.85

1.7

1.6

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

135

625

2.21

16.16

1.9

2.3

4.51

4.84

umol/l

0.32

456

(3036312) Salmon IgE Ab [Units/volume] in Serum

13.61

15.96

1.0

0.38

0.21

u/ml

0.22

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

6.24

15.47

1.1

1.0

0.33

1.11

u/ml

0.42

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

381

2.51

15.22

1.1

1.2

1.80

12.02

u/ml

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

328

2081

1.65

14.85

2.7

2.3

3561.03

5812.75

u/l

0.92

112

838

(40767503) Oxygen content in Capillary blood by calculation

104

449

2.36

14.69

3.2

2.5

17.15

16.52

1.59

104

440

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

406

2.44

14.68

1.2

50.00

443.85

titre

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

327

2092

1.63

14.31

3.7

3.5

4.45

4.54

pmol/l

0.93

303

1884

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1321

11051

1.35

13.98

2.1

1.9

1.38

1.34

mmol/l

1.05

1066

9581

(3019150) Specific gravity of Urine by Refractometry

829

6443

1.40

13.97

4.9

3.8

1.02

1.49

kg/l

0.80

547

4261

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

143

723

2.03

13.66

1.6

2.2

9.23

11.74

mg/l

3.30

137

684

(3048929) Epstein Barr virus Ab [Presence] in Serum

203

1154

1.81

13.63

1.4

1.2

—

(36660697) Celiac disease serology panel - Serum

376

2524

1.56

13.41

1.3

1.2

—

(3042936) Bacteria identified in Isolate by Culture

493

3514

1.48

13.25

2.0

1.9

—

(40758558) Short blood count panel - Blood

1003

8095

1.36

13.23

6.0

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

258

1591

1.68

13.01

2.3

2.2

3.54

6.99

ug/l

6.64

221

1432

(3023323) Follitropin [Units/volume] in Serum or Plasma

357

2388

1.56

12.91

1.4

21.95

25.83

iu/l

1.73

296

2050

(3023368) Bacteria identified in Blood by Culture

768

5973

1.38

12.68

4.8

4.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

236

2.75

12.57

1.2

1.1

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

11.03

12.51

1.0

9.40

7.96

u/ml

0.15

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2758

26189

1.63

12.37

5.8

5.1

2.81

mmol/l

0.02

2584

24836

(3007461) Platelets [#/volume] in Blood

2975

28971

3.19

12.33

28.1

20.7

265.64

261.42

e9/l

3.27

2946

28510

(3024731) MCV [Entitic mean volume] in Red Blood Cells

2975

28976

3.17

12.22

28.0

20.6

90.64

90.55

0.52

2961

28757

(3035941) MCH [Entitic mass]

2975

28976

3.17

12.22

28.0

20.6

30.19

30.15

0.64

2961

28757

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

2975

28977

3.17

12.20

28.6

21.0

41.71

40.41

0.59

2961

28743

(3026361) Erythrocytes [#/volume] in Blood

2975

28979

3.17

12.16

28.1

20.6

4.51

4.49

e12/l

2.32

2937

28454

(3010813) Leukocytes [#/volume] in Blood

2975

28982

3.16

12.10

28.1

20.7

6.80

6.68

e9/l

1.89

2939

28452

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2736

25953

1.59

12.05

5.3

4.6

4.74

4.76

mmol/l

0.40

2581

24704

(3000963) Hemoglobin [Mass/volume] in Blood

2975

28987

3.14

12.00

28.4

20.8

135.45

134.60

g/l

3.49

2961

28768

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

248

2.66

11.97

1.2

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2177

19830

1.35

11.96

4.2

3.5

—

(3018333) Ribosomal P Ab [Presence] in Serum

231

2.72

11.96

1.2

1.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

510

3728

1.44

11.93

2.2

1.9

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

249

2.65

11.88

1.2

1.1

—

(3009508) Creatinine [Moles/volume] in Urine

999

8166

1.33

11.79

3.6

3.4

7.98

7.56

mmol/l

1.84

844

7078

(3000570) Elastase.pancreatic [Mass/mass] in Stool

139

734

1.94

11.77

1.3

1.4

331.90

298.61

ug/g

1.03

404

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

178

1019

1.79

11.70

1.4

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

919

7429

1.34

11.67

2.3

2.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

828

6597

1.35

11.56

1.7

1.5

—

(3006245) CD3-CD19+ cells/cells in Blood

113

3.48

11.53

2.0

2.1

9.32

8.55

0.23

107

(40759836) Histone Ab [Presence] in Serum by Immunoblot

253

2.60

11.52

1.2

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

623

4747

1.39

11.48

2.7

2.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

243

2.63

11.37

1.2

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

147

800

1.88

11.37

1.3

1.2

75.50

92.74

titre

0.43

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2722

25847

1.55

11.27

5.1

4.5

1.48

1.51

mmol/l

3.12

2548

24491

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

559

4195

1.41

11.24

3.2

2.7

1.14

1.21

e6/l

0.12

287

2139

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

4.34

11.22

1.3

1.1

92.25

100.09

0.83

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

258

2.55

11.08

1.2

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

3.78

11.01

1.9

0.23

0.15

e9/l

0.98

(3035637) Corticotropin [Mass/volume] in Plasma

338

2.34

11.01

1.8

1.5

27.12

24.75

ng/l

0.18

338

(3017732) Neutrophils [#/volume] in Blood

480

3524

1.43

10.90

2.8

3.0

4.00

4.58

e9/l

1.71

439

3148

(3003458) Phosphate [Moles/volume] in Serum or Plasma

423

3038

1.46

10.80

5.2

5.6

1.02

1.04

mmol/l

0.98

401

2832

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

370

2591

1.49

10.74

7.6

5.8

—

(3008898) HLA-B27 [Presence]

211

1299

1.67

10.71

1.1

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

477

3510

1.43

10.68

1.9

2.1

29.44

29.18

0.45

463

3409

(3014051) Protein [Presence] in Urine by Test strip

985

8134

1.31

10.54

3.1

2.8

0.00

0.03

—

135

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

295

2.41

10.53

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

140

774

1.85

10.33

1.2

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

114

590

1.97

10.27

1.1

21.02

18.17

au/ml

0.11

167

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

181

2.79

10.23

2.6

2.4

243.82

217.93

e6/l

0.44

148

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

3.83

10.21

3.8

3.9

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

7.47

10.16

1.0

3.18

3.95

u/ml

0.19

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

172

2.82

10.01

2.7

2.3

575.58

550.97

e6/l

0.11

132

(3014765) Yersinia sp identified in Stool by Organism specific culture

139

775

1.83

9.99

1.2

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

664

5220

1.35

9.89

2.8

2.2

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

145

824

1.80

9.80

2.0

2.5

4.46

4.26

g/l

1.76

138

770

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

145

824

1.80

9.80

2.0

2.5

7.12

7.34

g/l

1.12

138

771

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

8.75

9.77

1.0

0.01

6.87

u/ml

0.49

(3018001) Oat IgE Ab [Units/volume] in Serum

8.75

9.77

1.1

1.0

0.30

0.24

u/ml

—

(42529406) Shigella sp [Presence] in Stool by Culture

139

782

1.82

9.72

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

150

865

1.77

9.66

1.1

7.10

4.15

eliau/ml

0.37

131

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

149

858

1.77

9.64

1.2

3.66

4.83

0.71

120

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

139

786

1.81

9.56

1.9

2.6

2.81

2.93

g/l

0.98

132

733

(3052851) Hemolysis interference index of Serum or Plasma

124

677

1.87

9.54

2.9

2.39

2.09

index

0.13

357

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

128

706

1.85

9.54

2.0

2.6

10.03

10.38

g/l

0.39

121

651

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

144

824

1.79

9.52

2.0

2.5

3.85

3.65

g/l

0.76

137

771

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

162

962

1.72

9.42

1.7

1.5

0.70

0.31

iu/ml

0.27

163

(1761868) Lipid panel - Serum or Plasma

1348

11717

1.27

9.38

3.3

2.8

—

(3004616) Nuclear Ab [Presence] in Serum

331

2.24

9.33

1.3

—

(3033658) Prothrombin time (PT) actual/Normal

797

6483

1.31

9.29

4.2

3.8

95.94

94.59

0.93

768

6325

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

478

3609

1.39

9.13

1.7

1.9

—

(3012516) Albumin [Mass/volume] in Urine

864

7119

1.30

9.13

3.7

3.5

40.93

46.76

mg/l

0.33

519

4433

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

153

2.84

9.11

1.8

2.8

921.65

926.59

u/ml

0.01

153

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

113

608

1.89

9.11

1.9

2.5

0.00

g/l

-0.00

548

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

112

601

1.90

9.10

1.5

1.4

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

117

637

1.87

9.10

1.9

2.4

0.01

0.02

g/l

0.25

105

589

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

560

4339

1.36

9.10

3.9

3.4

230.48

365.39

ng/l

0.63

337

2864

(3006184) Hemoglobin [Mass/volume] in Capillary blood

103

538

1.95

9.07

2.7

2.3

132.00

129.92

g/l

0.42

443

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

116

632

1.87

9.00

1.4

1.2

264.77

259.58

u/ml

0.07

396

(3020682) Albumin/Creatinine [Ratio] in Urine

873

7219

1.29

8.94

4.6

4.2

7.53

8.59

mg/mmol

0.29

507

4438

(3011985) Renin [Units/volume] in Plasma

364

2.14

8.90

1.6

32.72

66.40

mu/l

1.28

336

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

123

3.03

8.84

1.1

1.0

3.27

13.66

u/ml

5.08

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

132

754

1.79

8.80

1.4

1.3

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

7.18

8.72

1.1

0.03

0.02

u/ml

0.39

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

297

2.25

8.62

2.0

1.5

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

289

2012

1.48

8.61

2.1

2.6

74.32

72.66

ml/min/173m2

0.27

111

822

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1438

12681

1.26

8.57

2.9

2.7

—

estimate

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

363

2.12

8.57

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

392

2898

1.41

8.45

2.1

1.9

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2583

24527

1.37

8.30

4.4

3.9

1.30

1.24

mmol/l

3.91

2410

23087

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

167

2.66

8.29

1.8

1.6

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

9.46

8.27

1.1

0.03

0.13

u/ml

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

217

1434

1.55

8.26

1.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

409

2.03

8.26

1.1

0.96

1.10

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

350

2548

1.42

8.23

2.6

2.4

33.23

56.78

u/l

0.66

290

2141

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

105

572

1.87

8.18

2.0

2.5

0.00

g/l

-0.00

547

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

114

638

1.82

8.16

1.7

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

222

1479

1.54

8.15

9.5

8.6

24.66

24.83

mmol/l

0.30

217

1472

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

262

1812

1.49

8.06

1.1

1.0

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

115

651

1.80

7.93

1.3

1.4

92.99

31.33

e6/l

0.30

482

(3001686) Cold agglutinin [Titer] in Serum or Plasma

4.28

7.93

1.2

1.4

—

165.14

—

(3023419) Bacteria identified in Sputum by Culture

295

2.19

7.91

5.2

2.5

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

257

2.28

7.88

1.1

9.06

9.20

iu/ml

0.01

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

297

2.18

7.79

2.0

1.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

355

2617

1.40

7.77

2.1

1.8

—

(1002224) Polysomnography panel

226

1531

1.51

7.69

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

124

726

1.74

7.64

2.0

2.6

0.20

0.98

g/l

4.36

109

649

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

341

2507

1.41

7.58

4.4

4.5

225.63

240.30

u/l

1.00

314

2382

(3011412) CD3 cells [#/volume] in Blood

249

2.27

7.56

2.7

2.3

1553.75

1303.72

e6/l

1.10

215

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

115

663

1.76

7.48

1.4

1.5

377.99

1503.05

e6/l

1.39

527

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

336

2.08

7.44

1.4

1784.03

350.60

pmol/l

0.49

299

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

454

3506

1.35

7.44

2.4

2.0

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

412

1.97

7.41

2.1

1.6

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

7.65

7.38

1.0

0.01

0.07

u/ml

0.87

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

100

556

1.83

7.34

1.6

1.4

146.10

151.24

au/ml

0.14

152

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

365

2732

1.38

7.29

2.1

1.7

—

(37208534) Antinuclear antibody arbitrary concentration in serum

3.11

7.28

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

110

2.93

7.27

1.8

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

246

1720

1.47

7.18

1.5

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

531

1.83

7.18

1.2

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

206

2.35

7.05

1.6

1.5

33.41

36.62

0.21

119

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

8.78

7.04

1.1

0.01

0.07

u/ml

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

312

2294

1.40

6.92

2.2

2.3

0.23

0.22

g/l

1.76

291

2157

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

374

1.98

6.88

1.3

0.50

5.30

nmol/l

0.51

361

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.06

6.88

1.9

1.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

113

669

1.72

6.73

1.2

1.3

3.62

3.68

mmol/l

0.32

105

639

(3027945) Reticulocytes/Erythrocytes in Blood

327

2441

1.38

6.63

2.9

2.8

1.82

1.79

0.20

291

2190

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

200

2.32

6.59

2.0

2.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

108

636

1.72

6.57

1.7

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

746

6250

1.26

6.53

1.8

1.7

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

165

2.44

6.43

1.6

1.4

5.18

5.80

u/l

0.34

143

(3020779) Urea [Moles/volume] in Serum or Plasma

262

1894

1.42

6.41

6.6

7.6

7.65

8.48

mmol/l

1.30

253

1827

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

261

2.13

6.39

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

223

1566

1.46

6.38

1.9

1.7

279.62

298.69

mu/l

0.59

199

1402

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

483

3843

1.31

6.38

3.4

2.8

3.46

3.53

e6/l

0.04

207

1788

(3002256) Pathology report gross observation

451

3556

1.32

6.36

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

3.10

6.31

1.6

1.5

9.59

8.57

ug/l

0.76

(3030981) Hyaline casts [#/volume] in Urine by Automated count

262

1900

1.42

6.30

2.5

2.3

0.31

0.41

e6/l

0.30

254

1803

(3017446) Testosterone [Moles/volume] in Serum or Plasma

207

1440

1.47

6.22

2.6

2.2

11.38

11.57

nmol/l

0.11

180

1311

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

505

1.79

6.17

1.1

4.68

2.41

eliau/ml

0.51

257

(3025018) Bordetella pertussis Ab [Titer] in Serum

252

2.12

6.15

1.1

1.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

3.77

6.08

1.8

1.3

—

0.82

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

321

1.98

6.08

1.3

—

nmol/l

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

200

2815

0.69

6.00

4.4

31.06

32.35

1.03

143

1983

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

330

1.96

5.97

1.3

0.17

0.23

nmol/l

0.48

252

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

481

1.79

5.96

1.7

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

467

1.80

5.93

1.1

1.78

2.59

0.47

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

171

1157

1.51

5.91

2.3

2.2

—

(3034891) Synovial lining cells/cells in Synovial fluid

113

2.67

5.82

1.4

14.00

4.23

—

(3023520) Reticulocytes [#/volume] in Blood

247

1801

1.40

5.77

2.8

2.7

75.31

71.73

e9/l

0.69

175

1285

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

193

2.25

5.76

1.1

1.09

1.10

u/l

0.03

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

144

2.45

5.70

1.7

1.5

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

529

1.72

5.56

7.1

5.7

371.14

399.54

iu/ml

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

6.52

5.55

1.3

1.1

0.47

0.40

iu/ml

—

(3016502) Oxygen saturation in Arterial blood

283

2130

1.36

5.46

7.9

8.9

96.48

95.93

1.04

271

2066

(4027681) Cerebrospinal fluid IgG ratio and IgG index

213

2.13

5.32

1.4

1.2

0.59

0.63

ratio

0.27

135

(3049717) Cytology report of Urine Cyto stain

104

644

1.64

5.31

2.0

2.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

194

2.18

5.28

1.1

0.15

5.16

nmol/l

—

(3045414) Leukocytes [Presence] in Urine

328

2540

1.33

5.25

2.2

2.0

0.09

0.02

estimate

0.69

558

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

5.40

5.22

1.3

1.1

1.31

1.77

iu/ml

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

209

1511

1.41

5.15

1.6

1.5

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

268

2023

1.36

5.09

7.9

9.3

122.84

121.27

g/l

0.61

258

1978

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

272

1.97

5.07

1.0

1.2

31.65

37.05

mg/l

0.76

230

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

211

2.10

5.05

1.2

290.00

190.00

titre

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

159

2.28

5.05

1.3

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

100

622

1.63

5.03

2.1

1.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

342

2680

1.31

5.03

1.5

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

3.41

5.02

1.1

0.60

0.71

umol/24h

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

592

1.64

5.00

1.8

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

153

1050

1.48

4.98

1.4

1.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

103

649

1.61

4.93

1.1

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

282

1.93

4.92

1.7

1.6

63.26

58.17

0.38

174

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

480

1.71

4.90

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

105

666

1.60

4.89

2.1

1.5

—

(3002079) Sodium [Moles/time] in 24 hour Urine

130

2.40

4.88

1.3

1.5

128.23

154.65

mmol/24h

1.54

130

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

262

1.96

4.88

1.0

1.1

197.97

229.99

mg/l

0.99

231

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

143

2.32

4.84

1.3

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

202

2.09

4.80

1.7

1.2

—

(3007542) Rye IgE Ab [Units/volume] in Serum

4.85

4.80

1.1

1.0

0.07

1.34

u/ml

—

(3044290) Cell count panel - Cerebral spinal fluid

599

1.62

4.79

1.3

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

102

647

1.60

4.76

1.1

—

(3007700) Barley IgE Ab [Units/volume] in Serum

5.73

4.75

1.1

1.0

0.06

1.15

u/ml

—

(3042631) Mycobacterium sp identified in Specimen

258

1.95

4.73

3.2

2.5

—

(3010838) Calcium [Moles/time] in 24 hour Urine

486

1.69

4.70

2.1

2.0

4.57

5.27

mmol/24h

1.20

440

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

204

2.07

4.69

1.7

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

139

2.32

4.68

1.7

1.5

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

195

1422

1.40

4.60

3.0

2.8

122.54

160.35

ng/l

0.92

173

1276

(44816559) Phosphatidylethanol [Mass/volume] in Blood

179

1287

1.42

4.58

1.6

1.7

0.34

0.30

mg/l

0.33

575

(3008152) Bicarbonate [Moles/volume] in Arterial blood

175

1255

1.42

4.54

5.6

6.9

24.14

24.41

mmol/l

0.46

164

1201

(3024891) Influenza virus A+B Ag [Presence] in Specimen

122

816

1.52

4.52

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

188

2.09

4.46

1.1

1398.41

1495.39

miu/ml

0.25

188

(3045683) HLA typing for celiac disease panel - Blood or Tissue

216

2.01

4.41

1.0

—

(3003396) Base excess in Arterial blood by calculation

307

2416

1.30

4.39

7.7

8.3

1.02

0.88

mmol/l

0.29

247

1983

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

382

1.74

4.38

1.6

1.4

—

(3019977) pH of Arterial blood

308

2428

1.30

4.35

7.9

8.4

7.42

0.72

177

1309

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

225

1.97

4.30

1.3

1.4

2.04

1.95

mmol/l

0.11

211

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

5.52

4.28

1.6

1.33

1.19

mg/l

0.10

(3020123) Porphyrins [Interpretation] in Serum or Plasma

5.52

4.28

1.1

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

5.52

4.28

1.6

1.04

2.20

mg/l

0.38

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

5.52

4.28

1.6

0.39

3.05

mg/l

0.72

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

304

1.82

4.26

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

495

1.63

4.17

1.1

1.2

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

5.25

4.14

1.6

0.56

1.08

mg/l

0.82

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

102

671

1.54

4.11

2.5

2.8

—

(3000475) Leukocytes [#/volume] in Synovial fluid

593

1.57

4.06

1.8

1.7

13356.13

10789.79

e6/l

0.26

415

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

500

1.62

4.02

1.3

1.2

4.27

3.82

u/ml

0.05

164

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

333

1.76

3.99

1.0

1.1

—

4.24

—

(40768793) Breast Pathology biopsy report

116

790

1.49

3.99

1.4

1.3

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

305

2433

1.28

3.94

7.9

8.3

4.96

5.09

kpa

1.69

289

2345

(3027801) Oxygen [Partial pressure] in Arterial blood

304

2433

1.28

3.83

7.9

8.3

12.62

12.98

kpa

0.55

288

2348

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

109

743

1.48

3.75

1.6

1.4

0.39

0.43

nmol/l

0.18

592

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

487

1.60

3.71

1.3

4.14

4.28

u/ml

0.02

209

(4268621) Lupus anticoagulant assay

334

1.72

3.68

2.4

2.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

246

1.84

3.66

1.0

1.1

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

188

1418

1.35

3.65

2.3

1.9

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

232

1.87

3.64

1.3

1.2

61.59

61.66

u/l

0.00

212

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

110

2.28

3.61

1.2

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

156

2.06

3.61

1.7

1.4

—

(3000012) Reticulocyte production index

272

1.78

3.49

2.2

1.07

0.92

0.49

169

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

108

747

1.46

3.48

6.4

3.7

1.35

1.39

mg/l

0.20

696

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

430

3624

1.22

3.42

1.6

1.8

1.40

0.03

366

3238

(3019832) Treponema pallidum Ab [Presence] in Serum

548

4728

1.19

3.41

2.0

1.8

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.67

3.39

1.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

232

1824

1.29

3.38

3.6

87.09

78.73

ng/l

0.36

201

1608

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

508

1.55

3.35

1.5

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

254

1.78

3.33

1.1

121.11

113.86

pmol/l

0.35

254

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

122

2.14

3.25

3.6

3.3

7.92

8.52

mg/l

0.22

105

(3032773) Endomysium IgG Ab [Titer] in Serum

301

1.71

3.25

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

280

1.73

3.19

1.3

—

titre

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

510

4397

1.19

3.19

1.7

1.5

—

(40768795) Lymph node Pathology biopsy report

252

1.76

3.12

1.1

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

127

925

1.39

3.11

2.1

3.35

9.44

iu/l

0.54

405

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

115

825

1.41

3.08

2.1

2.6

3.62

3.58

g/l

0.13

104

782

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

7.51

3.05

1.0

1.1

0.04

0.03

u/ml

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

139

2.02

3.05

1.6

4.69

5.39

u/l

0.12

118

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

561

1.49

3.04

3.7

3.6

1.45

3.10

ratio

1.64

319

(3037756) Immunofixation for Serum or Plasma

409

1.58

3.02

1.5

1.7

—

(3051651) Icteric interference index of Serum or Plasma

140

2.01

3.00

2.5

3.3

0.61

0.84

index

1.43

140

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

425

3626

1.20

2.98

5.7

5.0

1.79

2.26

ug/l

2.02

386

3284

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

10.01

2.98

1.0

0.03

0.02

u/ml

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

507

1.51

2.97

1.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

631

1.46

2.94

4.4

3.8

37.40

61.62

mg/l

1.36

548

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

631

1.46

2.94

4.4

3.8

36.50

47.42

mg/l

0.70

548

(3002032) Base excess in Venous blood by calculation

256

2076

1.25

2.94

4.6

3.7

1.97

1.74

mmol/l

0.44

228

1808

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

657

1.44

2.92

1.3

1.2

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

267

1.70

2.85

2.3

30.89

32.24

0.92

267

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

164

1.90

2.85

2.9

2.6

0.90

0.70

e9/l

1.14

158

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

180

1403

1.30

2.85

3.4

3.3

5.10

5.14

kpa

0.28

173

1352

(4035726) Immunohistochemistry procedure

263

2148

1.25

2.84

1.5

1.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

261

2134

1.24

2.80

4.6

3.7

5.74

5.81

kpa

0.54

256

2072

(3000093) Morphology [Interpretation] in Blood Narrative

194

1.81

2.80

1.2

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

4.45

2.79

1.3

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

117

858

1.38

2.79

1.3

—

(3016750) Collection duration of Urine

124

2.02

2.76

1.9

2.5

478.29

496.42

min

0.33

(3020650) Glucose [Presence] in Urine

104

2.12

2.74

1.3

1.7

0.00

0.03

estimate

0.50

104

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

5.01

2.72

1.1

2.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

5.01

2.72

1.0

1.1

0.03

0.06

u/ml

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

428

1.53

2.72

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

428

1.53

2.72

1.3

—

(3009343) pH of Capillary blood

174

1360

1.30

2.71

3.5

3.3

7.42

0.82

152

1145

(3006653) Thiamine [Moles/volume] in Blood

146

1.93

2.70

1.2

1.4

143.71

130.17

nmol/l

0.91

146

(3009214) Lutropin [Units/volume] in Serum or Plasma

135

1020

1.34

2.67

1.7

1.3

11.67

10.70

u/l

0.30

112

829

(3012544) pH of Venous blood

260

2142

1.23

2.61

4.7

3.7

7.38

0.39

147

1191

(3044640) Blood type and Crossmatch panel - Blood

949

8693

1.13

2.61

2.4

2.2

—

(3024869) Neuronal Ab [Presence] in Serum

3.34

2.60

1.0

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

244

1.69

2.60

1.2

1.3

4.21

5.48

umol/l

1.60

221

(3018851) Theophylline [Moles/volume] in Serum or Plasma

4.67

2.59

2.6

1.3

44.43

50.00

umol/l

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

142

1.91

2.55

1.1

—

(3033099) Centromere Ab [Titer] in Serum

2.43

2.54

1.3

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

339

2878

1.20

2.53

5.1

4.1

21.58

21.17

0.17

157

1260

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.51

2.53

1.2

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.51

2.53

1.2

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.51

2.53

1.2

1.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

469

1.48

2.52

2.8

2.6

137.57

102.52

ug/min

0.13

289

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

309

1.60

2.50

4.3

5.0

32.80

121.22

u/ml

1.09

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

202

1.74

2.48

1.2

1.1

1.07

1.04

ratio

0.83

164

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

471

1.48

2.47

1.1

120.74

117.47

0.44

428

(3028433) Virus identified in Specimen by Culture

2.24

2.44

1.2

1.3

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.09

2.42

1.0

1.4

104.00

95.93

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

153

1197

1.29

2.40

3.3

3.1

2.11

1.67

mmol/l

0.88

108

881

(3022493) Free Hemoglobin [Mass/volume] in Plasma

2.12

2.38

1.3

4.3

60.33

58.77

mg/l

0.04

(3016650) Hepatitis A virus Ab [Presence] in Serum

517

1.44

2.37

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

111

1.99

2.35

1.4

1.5

82.95

325.38

nmol/24h

0.48

111

(3032743) Legionella sp IgG Ab [Presence] in Serum

4.62

2.27

1.2

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

4.62

2.27

1.2

1.0

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

134

1.87

2.26

1.5

1.2

12.74

26.04

u/l

1.07

115

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

112

847

1.33

2.25

2.2

2.5

171.28

176.01

0.23

106

811

(3024263) Appearance of Synovial fluid

106

1.99

2.25

1.3

2.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.90

2.25

1.3

1.9

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

5.56

2.21

1.0

0.56

1.42

u/ml

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.51

2.18

1.2

1.1

—

(4146454) Self-monitoring of blood glucose

213

0.42

2.18

1.9

2.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

144

1134

1.28

2.17

1.5

1.4

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

188

1.71

2.17

2.3

1.6

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

2.08

2.17

1.2

1.4

99.36

120.92

nmol/l

0.38

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

637

1.38

2.16

1.4

1.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

101

1.99

2.15

1.0

1.1

105.43

93.52

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

175

1414

1.25

2.14

1.4

273.67

223.08

miu/ml

0.88

726

(3051611) Lipemic interference index of Serum or Plasma

227

1.64

2.14

2.9

3.0

17.71

13.65

index

0.81

140

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

2.62

2.14

1.7

—

(3020393) Adenovirus Ag [Presence] in Stool

3.21

2.09

1.8

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.21

2.09

2.0

2.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

214

1.64

2.06

2.9

2.3

15.64

28.42

mg/l

2.68

144

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

482

1.42

2.05

1.1

111.92

1222.87

iu/ml

0.49

110

(3009015) Lactate [Moles/volume] in Synovial fluid

3.51

2.05

1.0

1.4

4.81

5.85

mmol/l

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

3.51

2.05

1.6

2.3

3.90

2.50

mg/l

—

(3036071) Salmonella sp Ab [Titer] in Serum

110

1.92

2.05

1.0

1.1

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

190

0.42

2.04

10.1

14.9

568.88

7662.31

nmol/l

—

183

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

722

0.67

2.04

1.2

1.3

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

4.01

2.04

1.3

1.8

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

4.01

2.04

1.3

1.1

—

(3036489) Thrombin time

136

1074

1.28

2.03

1.9

2.1

20.10

20.43

0.53

114

927

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

147

1.78

2.02

1.0

1.1

99.50

91.92

0.52

119

(3000991) Gas panel - Venous blood

229

1920

1.21

1.99

9.7

9.3

—

(3002619) Bacteria identified in Specimen by Culture

2.15

1.98

1.1

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

718

1.33

1.96

1.9

2.7

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.19

1.94

2.4

3.8

12.11

10.73

kpa

0.46

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.19

1.94

2.4

3.8

5.17

4.72

kpa

0.91

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.57

1.94

1.1

1.4

—

(3001729) Color of Synovial fluid

3.76

1.93

1.2

1.8

—

(3004775) Volume in Urine collected for unspecified duration

157

1.73

1.92

2.0

2.4

720.25

638.73

0.41

110

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1284

0.76

1.91

1.1

0.74

0.62

ratio

0.86

149

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

107

1.87

1.86

1.2

1.1

—

(3003181) Sodium [Moles/volume] in Urine

408

1.43

1.85

1.2

1.4

59.45

62.45

mmol/l

0.25

337

(3001019) Free T4 and TSH panel - Serum or Plasma

236

2001

1.19

1.84

1.8

1.7

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

196

0.46

1.84

11.7

20.5

1101.44

1452.16

nmol/l

—

190

(3009871) Measles virus Ab [Titer] in Serum

122

1.81

1.84

1.8

1.7

2755.56

4126.32

titre

—

(4094501) Cardiovascular stress test using bicycle ergometer

657

1.33

1.82

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

220

1856

1.20

1.82

2.8

3.2

40.54

54.25

u/ml

0.54

215

1793

(3045142) Bone marrow Pathology biopsy report

262

1.53

1.81

1.3

1.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.09

1.76

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

124

1.78

1.75

2.3

2.2

58.67

184.66

umol/l

—

(3047181) Lactate [Moles/volume] in Blood

627

1.33

1.75

3.7

6.3

1.30

1.25

mmol/l

0.24

546

(3034426) Prothrombin time (PT)

1.90

1.75

1.2

1.3

27.11

27.97

0.41

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

102

794

1.29

1.74

2.0

3.16

1.65

ug/l

0.31

716

(21494890) Protein electrophoresis panel - 24 hour Urine

201

1.60

1.74

1.9

2.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

140

1.72

1.71

1.0

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

115

912

1.27

1.70

1.8

1.9

1.44

1.50

g/l

0.34

799

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

458

1.38

1.70

1.4

1.6

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

762

1.30

1.69

2.1

2.3

244.49

338.20

ug/l

0.53

711

(4195642) Thrombophilia screening test

467

1.38

1.69

1.2

—

(3011288) Drugs identified in Urine by Screen method Nominal

147

1201

1.24

1.69

2.1

2.8

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

450

1.39

1.69

1.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

494

1.36

1.66

1.6

482.28

357.25

mu/l

0.37

399

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

659

1.31

1.66

1.8

1.6

—

(3036670) Protein [Mass/volume] in Synovial fluid

2.10

1.65

1.3

1.2

32.86

39.28

g/l

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

244

1.52

1.65

1.8

1.6

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.03

1.64

2.6

1.2

—

(3004451) EKG impression Narrative

105

1.81

1.63

1.3

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.15

1.61

1.2

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

489

1.36

1.60

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

144

1743

0.82

1.59

1.4

—

(3050794) Legionella sp Ab [Presence] in Serum

3.00

1.58

1.2

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.70

1.58

1.0

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

313

1.44

1.57

1.7

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

272

1.48

1.56

1.8

1.5

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

155

1286

1.22

1.56

11.1

10.4

24.50

24.29

mmol/l

0.36

150

1266

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

257

1.48

1.53

1.1

17.29

15.28

u/ml

0.10

120

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

307

1.44

1.52

1.7

1.4

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

109

1349

0.80

1.50

1.1

1.48

1.56

g/l

2.75

109

1349

(3024522) Salmonella sp identified in Specimen by Organism specific culture

308

1.43

1.49

1.7

1.4

—

(3016244) Insulin [Units/volume] in Serum or Plasma

235

1.50

1.46

2.6

3.2

19.64

24.18

mu/l

0.59

224

(3028679) Herpes simplex virus Ab [Presence] in Serum

211

1.52

1.45

1.4

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

179

1.57

1.45

5.7

7.3

11.97

112.51

ug/l

0.53

112

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

113

915

1.24

1.45

2.1

2.2

97.21

94.90

0.66

107

878

(3027008) Opiates [Presence] in Urine

197

1687

1.18

1.43

1.9

2.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

110

1.73

1.42

1.2

1.0

—

(3000764) Benzodiazepines [Presence] in Urine

196

1679

1.18

1.42

1.9

2.0

—

(3027944) Amphetamines [Presence] in Urine

195

1672

1.18

1.40

1.9

2.0

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

141

1175

1.21

1.39

10.4

11.1

16.35

15.98

0.89

132

1130

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

511

1.32

1.38

1.1

—

(3028300) Cannabinoids [Presence] in Urine

197

1695

1.17

1.36

2.0

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.83

1.35

1.0

1.4

—

(40757494) Bilirubin.total [Moles/volume] in Blood

112

1.70

1.35

1.3

2.8

—

27.64

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.87

1.34

2.9

2.2

11.76

15.72

umol/l

1.11

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

113

1.69

1.31

1.1

1.3

194.28

155.70

pmol/l

0.72

113

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.81

1.31

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.81

1.31

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.81

1.31

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.81

1.31

1.2

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

225

1.47

1.31

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

346

3840

0.89

1.30

1.7

1.8

3.48

3.38

ratio

0.72

242

2862

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

105

856

1.23

1.29

2.2

2.0

—

(40768806) Pleura Pathology biopsy report

172

0.52

1.29

1.6

1.7

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

153

1.57

1.28

2.0

2.8

47.47

43.76

0.71

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.78

1.28

1.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

293

1.40

1.28

1.7

1.4

—

(40757373) Influenza virus identified in Isolate

2.29

1.26

3.8

1.6

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.29

1.26

1.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

294

1.40

1.26

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

354

1.36

1.25

1.3

1.7

—

(3022621) pH of Urine by Test strip

252

2226

1.14

1.25

2.9

2.4

6.13

6.14

0.07

166

1419

(3005988) Vibrio sp identified in Specimen by Organism specific culture

295

1.40

1.24

1.7

1.4

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.23

1.24

3.8

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

115

1382

0.83

1.24

1.5

1.19

1.15

ratio

0.14

811

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.86

1.23

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

126

1501

0.83

1.23

1.5

63.23

60.68

ug/l

0.20

1249

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

204

1.48

1.22

2.0

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

204

1.48

1.22

2.0

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

204

1.48

1.22

2.0

1.5

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.97

1.22

1.2

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

239

1.43

1.18

1.1

275.91

296.68

mg/l

1.03

217

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

116

1385

0.83

1.18

1.4

1.5

0.99

0.94

ratio

0.63

814

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

116

1385

0.83

1.18

1.4

1.5

1.11

1.21

ratio

0.57

820

(3039000) Anion gap in Blood by calculation

402

1.32

1.17

4.4

8.0

11.25

11.34

mmol/l

0.08

361

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

142

1208

1.18

1.16

1.7

1.5

—

(3018572) Chloride [Moles/volume] in Blood

403

1.32

1.15

4.4

7.9

104.30

105.38

mmol/l

0.90

362

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.00

1.15

0.0

2.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.69

1.13

1.0

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

292

1.37

1.13

1.7

1.4

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

449

1.30

1.12

2.1

1.8

—

7.25

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.34

1.12

1.0

1.2

1.79

1.69

umol/24h

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

242

2151

1.14

1.11

3.2

3.1

0.81

0.73

ug/l

0.23

153

1303

(3016879) Cocaine [Presence] in Urine

179

1558

1.16

1.11

1.9

2.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.71

1.11

2.4

3.5

2.37

1.29

0.56

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

184

1.47

1.10

1.2

1.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

209

1.44

1.10

3.2

3.8

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.26

1.10

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.38

1.09

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.19

1.08

1.3

1.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

116

1369

0.84

1.06

1.4

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.12

1.05

1.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

690

6495

1.08

1.04

2.4

2.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.96

1.03

1.8

1.5

—

(3008295) Osmolality of Serum or Plasma

272

1.36

1.02

1.3

1.5

278.76

278.29

mosm/kgh2o

0.04

209

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

106

1.61

1.02

1.8

2.3

117.47

139.64

0.94

100

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.92

1.02

1.9

2.8

5.11

5.23

ug/l

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

154

1337

1.16

1.01

2.1

2.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

100

1189

0.84

1.00

1.6

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1156

0.83

1.00

1.5

—

(21494755) Public health laboratory ask at order entry panel

300

3297

0.90

0.98

1.4

1.3

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

2.18

0.98

1.0

1.1

—

29.71

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

159

0.56

0.98

1.4

438.66

382.62

u/l

—

152

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.97

0.0

1.1

—

(3023410) Appearance of Cerebral spinal fluid

301

1.33

0.97

1.3

1.7

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.85

0.96

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.85

0.96

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

199

1.41

0.95

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

117

0.51

0.94

2.0

2.5

151.83

147.63

nmol/l

—

104

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

118

0.51

0.94

1.2

12.67

11.89

u/l

—

108

(3010937) Rubella virus Ab [Presence] in Serum

2.15

0.91

1.2

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

773

1.20

0.91

2.0

1.9

—

(3001186) Copper [Moles/volume] in Serum or Plasma

1.63

0.90

1.1

1.3

16.21

17.39

umol/l

0.79

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

146

1280

1.15

0.87

1.9

1.6

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

170

1.42

0.85

1.2

1.4

65.83

73.58

umol/l

1.53

170

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.76

0.83

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.69

0.82

1.0

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

243

2665

0.90

0.80

1.5

1.6

836.53

1004.85

mu/l

3.08

193

2252

(3005033) Fetal Nuchal fold Thickness US

1139

0.86

0.80

1.5

1.38

1.25

1.39

816

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

164

1.41

0.79

1.2

1.1

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

0.00

0.79

0.0

1.7

—

8.70

—

(3037121) Protein [Mass/volume] in Urine

804

0.83

0.79

2.2

3.4

246.38

344.99

mg/l

0.48

341

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.67

0.78

5.1

2.9

1.84

1.96

ratio

0.13

(44790047) Parainfluenza type 1 nucleic acid detection

340

1.27

0.77

2.0

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

340

1.27

0.77

2.0

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

340

1.27

0.77

2.0

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

340

1.27

0.77

2.0

1.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.00

0.76

0.0

2.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

143

1267

1.14

0.76

1.5

1.6

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

149

1.41

0.75

1.5

1.7

—

958781.58

iu/ml

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.57

0.75

1.1

1.0

59.32

40.77

iu/ml

0.22

(3042517) Benzodiazepines panel - Urine

1.84

0.73

5.0

2.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

193

1.35

0.73

1.2

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

644

1.18

0.73

1.7

1.4

20.59

25.09

u/l

0.57

546

(3007930) Methemoglobin/Hemoglobin.total in Blood

812

1.16

0.72

4.6

5.5

0.92

0.88

0.44

763

(4281824) Cell count and differential, peritoneal fluid

310

0.74

0.71

1.0

1.1

—

(3045788) Cell count panel - Pleural fluid

170

0.65

0.70

1.6

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.53

0.69

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

248

1.29

0.68

1.2

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.85

0.68

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.85

0.68

1.0

89.60

85.33

titre

—

(40768800) Prostate Pathology biopsy report

213

1.32

0.68

1.3

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

723

1.17

0.68

1.4

1.3

2.89

3.89

ug/l

1.16

663

(3010144) Erythrocytes [#/volume] in Synovial fluid

214

1.31

0.66

1.6

1.4

75074.75

77687.44

e6/l

0.01

148

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.54

0.65

3.5

2.8

0.59

0.61

mmol/l

0.84

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.57

0.65

2.0

2.3

—

(3045424) Erythrocytes [Presence] in Urine

145

1302

1.12

0.65

1.9

2.0

0.07

0.58

estimate

0.44

449

(3025130) Human papilloma virus identified in Specimen

699

1.16

0.64

2.1

1.9

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

260

1.27

0.64

1.3

1.6

—

(3052592) Norovirus Ag [Presence] in Stool

1.73

0.64

1.0

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

112

1.43

0.63

1.6

1.3

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

2347

23178

1.06

0.63

22.5

16.9

332.49

332.15

g/l

1.18

2336

23049

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

252

1.27

0.62

2.0

1.7

—

(3044927) Protein electrophoresis panel - Urine

188

0.69

0.62

1.3

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.67

0.61

1.4

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

434

1.20

0.61

2.1

1.4

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

0.00

0.60

0.0

1.2

—

21.14

—

(3044242) Glucose [Moles/volume] in Arterial blood

122

1.40

0.60

2.5

2.4

9.10

8.51

mmol/l

0.19

122

(40765089) Chromosome analysis panel - Blood by G-banded

122

1.40

0.60

1.0

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

140

1263

1.11

0.59

1.5

1.7

3.44

4.61

mg/l

0.93

107

913

(3014891) Appearance of Pleural fluid

0.00

0.58

0.0

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

585

1.17

0.58

1.6

1.8

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

106

1.42

0.57

1.0

1.1

1.60

383.04

ng/l

—

(3012441) Differential panel - Pleural fluid

173

0.69

0.57

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

115

1.39

0.56

2.6

1.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

115

1.39

0.56

1.6

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

115

1.39

0.56

2.6

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

115

1.39

0.56

2.6

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

115

1.39

0.56

2.6

1.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

515

1.17

0.54

2.1

2.6

0.89

0.90

nmol/l

0.04

449

(1617658) Protocol used for examination of sentinel lymph nodes

249

0.76

0.52

1.1

—

(4198724) Urine methamphetamine measurement

152

1.32

0.52

1.3

1.8

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

0.61

0.52

1.8

2.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

100

1.40

0.51

1.3

1.1

—

(4015189) Microbial culture of sputum

1.50

0.51

1.2

3.0

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

602

1.15

0.51

2.6

3.2

0.38

0.35

iu/ml

0.36

315

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

135

1.34

0.51

1.0

1.1

—

(40768441) Liver Pathology biopsy report

206

1.26

0.51

1.4

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.47

0.50

3.0

1.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

101

1.39

0.49

1.0

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

216

1.25

0.49

1.3

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

178

0.73

0.48

2.2

3.4

27.34

35.86

mg/l

—

133

(3003434) Protein [Mass/volume] in Pleural fluid

222

0.76

0.47

1.5

30.98

33.12

g/l

0.27

202

(3003694) ABO and Rh group [Type] in Blood

902

8766

1.04

0.47

1.7

1.6

—

(44806071) Cardiolipin IgM antibody measurement

1.46

0.46

1.0

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

893

1.11

0.45

4.5

5.1

1.71

1.60

0.45

845

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

274

2903

0.94

0.45

1.5

1.6

3.61

3.46

mmol/l

1.24

176

1964

(21494814) CD8 cells/Lymphocytes in Specimen

103

1.36

0.45

1.9

2.2

32.36

29.65

0.36

103

(3032057) Clostridioides difficile [Presence] in Stool

1.61

0.43

2.0

1.9

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

196

0.76

0.42

1.5

1.3

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.56

0.42

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

194

1.24

0.42

1.3

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.47

0.40

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.47

0.40

1.0

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

1.39

0.38

2.4

2.1

1.17

1.22

mmol/l

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.39

0.38

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

225

1.20

0.37

1.8

1.5

1.37

1.16

promille

0.33

181

(3006462) Nitrate [Presence] in Urine

116

1.29

0.37

2.3

2.7

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

125

1.28

0.37

1.4

1.5

10.38

12.92

u/l

0.72

119

(3024471) HLA-A [Type]

0.64

0.35

1.0

—

(3024932) HLA-DR beta [Type]

0.64

0.35

1.0

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

258

1.16

0.31

1.3

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

390

1.13

0.30

2.0

1.7

—

1825.45

—

(3029396) Erythrocyte agglutination [Presence] in Blood

142

0.77

0.30

3.5

3.2

—

(40768446) Kidney Pathology biopsy report

102

1.28

0.30

1.8

1.6

—

(3006270) Folate [Moles/volume] in Blood

203

1.18

0.29

1.1

384.37

393.37

nmol/l

0.07

189

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

176

1.19

0.28

1.3

2.1

1.75

1.87

u/field

0.08

106

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

184

0.81

0.28

1.7

1.2

4.80

8.96

mm/h

3.23

184

(3027456) Digoxin [Moles/volume] in Serum or Plasma

299

1.14

0.27

4.1

3.5

0.74

0.82

nmol/l

0.68

249

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.70

0.26

1.0

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

493

1.10

0.24

5.4

3.5

19.21

22.21

mg/l

0.40

336

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.27

0.24

1.7

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.27

0.24

1.7

1.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.32

0.23

2.0

1.7

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

1.28

0.23

1.0

1.1

—

(4211845) Urine protein measurement

134

1.20

0.22

2.2

2.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

144

1.18

0.22

1.2

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.19

0.21

1.4

1.3

5.64

5.63

mmol/l

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.21

0.0

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.2

—

379.45

—

(3022670) pH of Venous cord blood

0.00

0.21

0.0

1.2

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

5.4

—

103.00

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

254.00

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

0.21

0.0

1.3

—

7.26

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.0

—

3.80

—

(3006598) pH of Arterial cord blood

0.00

0.21

0.0

1.3

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

0.21

0.0

1.3

—

2.92

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.21

0.0

4.8

—

107.33

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

10.8

—

(40760410) HLA-B [Type] by High resolution

0.00

0.21

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.21

0.0

1.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

177

0.85

0.21

1.5

1.4

238567.78

92295.78

e6/l

—

(40758358) Immune stain study

0.00

0.21

0.0

1.0

—

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

0.00

0.21

0.0

1.2

—

6.67

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.24

0.21

3.3

1.6

—

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

0.00

0.20

0.0

1.4

—

55.33

—

(1761482) Bacteria [#/volume] in Urine by Culture

479

0.92

0.19

3.9

3.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.22

0.19

3.3

1.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.22

0.19

3.3

1.6

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.15

0.19

1.2

1.5

1.18

1.19

mmol/l

—

(40758292) HTLV I+II Ab panel - Serum

1.17

0.17

1.1

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

416

1.08

0.17

2.3

2.6

36.54

33.10

iu/ml

—

(3042733) HLA Ab [Presence] in Serum

1.22

0.17

6.1

4.5

—

(3047189) Immunofixation for 24 hour Urine

101

1.19

0.16

1.5

1.6

—

(40765096) Chromosome analysis panel by Banding

1.16

0.16

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.16

0.16

1.0

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.16

0.16

1.4

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

105

1004

1.05

0.16

1.4

1.5

66.39

59.69

ug/l

0.65

105

1004

(3039443) Prostate specific Ag panel - Serum or Plasma

235

1.11

0.15

1.8

1.6

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1.14

0.15

1.1

1.9

38.53

40.78

g/l

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.14

0.15

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

522

0.94

0.14

4.1

3.9

98.43

27.45

u/ml

0.54

509

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

253

0.91

0.13

1.8

2.2

15.75

24.07

mg/l

—

109

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

201

0.89

0.13

1.5

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

159

0.88

0.13

1.9

1.8

—

(3000330) Specific gravity of Urine by Test strip

123

1188

1.04

0.13

3.0

1.02

ratio

0.05

107

1058

(21494434) Karyotype in Bone marrow

179

0.89

0.12

1.3

1.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

268

1.08

0.12

3.5

2.4

1.58

1.20

g/24h

0.31

162

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.16

0.11

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

172

1.11

0.11

2.3

1.5

0.55

0.49

e9/l

0.48

172

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

134

1.12

0.11

1.6

1.7

68.99

98.42

ng/l

2.73

134

(3004119) Hemoglobin [Mass/volume] in Venous blood

134

1304

1.03

0.10

4.8

3.1

132.12

130.22

g/l

0.58

129

1272

(3022313) Gas panel - Capillary blood

941

0.97

0.10

3.2

3.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.14

0.10

4.4

1.7

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

145

1.10

0.09

1.1

1.0

912.50

761.99

ng/l

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.09

0.09

1.0

5.70

5.19

u/ml

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

0.81

0.08

1.2

1.5

32.60

60.45

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

146

1.10

0.08

1.1

1.0

355.70

302.40

ng/l

—

101

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

805

0.97

0.08

3.8

3.6

22.94

1992.23

u/ml

0.95

695

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

381

1.05

0.08

1.3

1.2

18.98

35.22

u/l

1.02

331

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

227

2233

1.02

0.08

3.8

4.3

72.63

33.06

ug/l

0.38

175

1734

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.80

0.07

1.0

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

147

1.09

0.07

1.1

1.0

44.07

42.54

ng/l

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

111

0.90

0.06

1.8

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

111

0.90

0.06

1.8

1.7

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

139

1.08

0.05

1.0

1.1

—

(3017569) Oxygen content in Arterial blood

110

1.09

0.05

2.9

2.7

14.33

16.61

1.84

110

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

199

1.06

0.04

2.0

2.3

—

(4034850) Laboratory test

795

0.98

0.04

14.0

8.9

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

121

1.07

0.03

1.0

1.8

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

361

0.97

0.03

1.4

1.5

—

(3019225) pH of Specimen

215

2168

0.99

0.03

3.7

7.33

7.35

0.24

166

1553

(43055514) Macroprolactin [Presence] in Serum or Plasma

108

0.93

0.03

2.0

1.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

247

0.97

0.01

1.3

2.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

117

1164

1.01

0.00

1.7

1.8

—

(3017704) Immunofixation for Urine

105

1.05

0.00

1.1

1.8

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

155

0.97

0.00

1.7

1.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

241

1.00

0.00

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

208

1.01

0.00

9.0

3.6

—

(4024509) Urine culture

118

1184

1.00

0.00

2.1

1.9

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.6

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.3

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

0.0

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.1

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.0

1.3

—

33.64

—

(3014271) Vancomycin [Susceptibility]

0.92

0.00

2.3

2.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.93

-0.00

1.0

1.2

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

-0.00

0.0

1.0

—

1.20

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

-0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3013762) Body weight Measured

0.00

-0.00

0.0

1.5

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

-0.00

0.0

5.8

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

5.9

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.1

—

154.00

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

-0.00

0.0

2.5

—

(3036180) Methadone [Presence] in Urine

0.00

-0.00

0.0

2.5

—

(4133840) Spirometry

0.99

-0.00

1.0

1.2

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

-0.00

0.0

1.2

—

(3044007) Cell count panel - Peritoneal fluid

0.87

-0.00

1.5

1.9

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.01

-0.00

1.0

1.1

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

-0.00

0.0

1.2

—

70.88

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3022689) Creatine [Moles/volume] in Urine

0.94

-0.00

1.0

1.6

6.91

7.48

mmol/l

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.89

-0.00

1.0

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.85

-0.00

1.0

1.3

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_URTICA_DERTMATOG and mortality.

Females

Parameter	HR [95% CI]	p-value
L12_URTICA_DERTMATOG	0.738 [0.63, 0.86]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.16

During the follow-up period (1.1.1998 — 31.12.2019), 366 out of 9810 females with L12_URTICA_DERTMATOG died.

Males

Parameter	HR [95% CI]	p-value
L12_URTICA_DERTMATOG	0.818 [0.71, 0.94]	0.006
Birth year	0.996 [0.99, 1.01]	0.415

During the follow-up period (1.1.1998 — 31.12.2019), 289 out of 3744 males with L12_URTICA_DERTMATOG died.

Mortality risk

Mortality risk for people of age

years, who have L12_URTICA_DERTMATOG.

N-year risk	Females	Males
1	0.082%	0.179%
5	0.449%	1.141%
10	1.149%	2.936%
15	2.057%	5.859%
20	3.711%	10.096%

Relationships between endpoints

↥

Index endpoint: L12_URTICA_DERTMATOG – Dermatographic urticaria

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Dermatographic urticaria

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints